https://cvvr.hms.harvard.edu/publication/a-highly-unusual-v1-region-of-env-in-an-elite-controller-of-hiv-infection/2020-03-11T15:04:55-04:00https://cvvr.hms.harvard.edu/publication/a-htrf-based-competitive-binding-assay-for-screening-specific-inhibitors-of-hiv-1-capsid-assembly-targeting-the-c-terminal-domain-of-capsid/2020-03-23T09:30:58-04:00https://cvvr.hms.harvard.edu/publication/a-meta-analysis-of-passive-immunization-studies-shows-that-serum-neutralizing-antibody-titer-associates-with-protection-against-shiv-challenge/2020-04-01T00:17:59-04:00https://cvvr.hms.harvard.edu/publication/a-microbial-expression-system-for-high-level-production-of-scfv-hiv-neutralizing-antibody-fragments-in-escherichia-coli/2020-04-01T00:17:25-04:00https://cvvr.hms.harvard.edu/publication/a-natural-impact-nk-cells-at-the-intersection-of-cancer-and-hiv-disease/2020-03-11T15:08:31-04:00https://cvvr.hms.harvard.edu/publication/a-vaccine-induced-gene-expression-signature-correlates-with-protection-against-siv-and-hiv-in-multiple-trials/2020-04-01T00:16:49-04:00https://cvvr.hms.harvard.edu/publication/assessing-the-safety-and-pharmacokinetics-of-the-monoclonal-antibodies-vrc07-523ls-and-pgt121-in-hiv-negative-women-in-south-africa-study-protocol-for-the-caprisa-012a-randomised-controlled-phase-i/2020-04-01T00:16:18-04:00https://cvvr.hms.harvard.edu/publication/broad-and-potent-neutralizing-antibodies-recognize-the-silent-face-of-the-hiv-envelope/2019-12-30T12:11:42-05:00https://cvvr.hms.harvard.edu/publication/decreased-jc-virus-specific-antibody-dependent-cellular-cytotoxicity-in-hiv-seropositive-pml-survivors/2020-05-19T13:47:51-04:00https://cvvr.hms.harvard.edu/publication/differential-role-for-phosphorylation-in-alternative-polyadenylation-function-versus-nuclear-import-of-sr-like-protein-cpsf6/2020-03-23T09:30:58-04:00https://cvvr.hms.harvard.edu/publication/difficult-to-neutralize-global-hiv-1-isolates-are-neutralized-by-antibodies-targeting-open-envelope-conformations/2019-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/disrupting-mlv-integrasebet-protein-interaction-biases-integration-into-quiescent-chromatin-and-delays-but-does-not-eliminate-tumor-activation-in-a-myc-runx2-mouse-model/2020-03-23T09:30:58-04:00https://cvvr.hms.harvard.edu/publication/dominant-negative-ma-ca-fusion-protein-is-incorporated-into-hiv-1-cores-and-inhibits-nuclear-entry-of-viral-preintegration-complexes/2020-03-23T09:30:58-04:00https://cvvr.hms.harvard.edu/publication/framework-mutations-of-the-10-1074-bnab-increase-conformational-stability-manufacturability-and-stability-while-preserving-full-neutralization-activity/2019-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/harvard-hiv-and-aging-workshop-perspective-and-priorities-from-claude-d-pepper-centers-and-centers-for-aids-research/2019-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/hiv-1-integrase-tetramers-are-the-antiviral-target-of-pyridine-based-allosteric-integrase-inhibitors/2020-03-23T09:30:58-04:00https://cvvr.hms.harvard.edu/publication/hiv-1-neutralizing-antibody-signatures-and-application-to-epitope-targeted-vaccine-design/2020-04-01T00:15:34-04:00https://cvvr.hms.harvard.edu/publication/hiv-1-vaccination-by-needle-free-oral-injection-induces-strong-mucosal-immunity-and-protects-against-shiv-challenge/2020-04-01T00:14:53-04:00https://cvvr.hms.harvard.edu/publication/hiv-specific-humoral-immune-responses-by-crispr-cas9-edited-b-cells/2019-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/immunization-expands-b-cells-specific-to-hiv-1-v3-glycan-in-mice-and-macaques/2019-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/impact-of-cmv-infection-on-natural-killer-cell-clonal-repertoire-in-cmv-naive-rhesus-macaques/2019-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/knowns-and-unknowns-of-assaying-antibody-dependent-cell-mediated-cytotoxicity-against-hiv-1-2019/2019-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/lack-of-therapeutic-efficacy-of-an-antibody-to-%ce%b14%ce%b27-in-sivmac251-infected-rhesus-macaques/2020-03-20T14:42:02-04:00https://cvvr.hms.harvard.edu/publication/memory-and-antigen-specific-nk-cell-responses-in-hiv-siv-infections-a-roadmap-to-cell-based-therapeutics/2019-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/monkeying-around-using-nonhuman-primate-models-to-study-nk-cell-biology-in-hiv-infections/2019-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/multifaceted-hiv-integrase-functionalities-and-therapeutic-strategies-for-their-inhibition/2020-03-23T09:30:58-04:00https://cvvr.hms.harvard.edu/publication/nk-cells-contribute-to-the-immune-risk-profile-in-kidney-transplant-candidates/2019-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/non-linear-multidimensional-flow-cytometry-analyses-delineate-nk-cell-phenotypes-in-normal-and-hiv-infected-chimpanzees/2019-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/priming-with-a-potent-hiv-1-dna-vaccine-frames-the-quality-of-immune-responses-prior-to-a-poxvirus-and-protein-boost/2019-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/reactivation-of-bk-virus-after-double-umbilical-cord-blood-transplantation-in-adults-correlates-with-impaired-reconstitution-of-cd4-and-cd8-t-effector-memory-cells-and-increase-of-t-regulatory-c/2019-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/replication-competent-nyvac-kc-yields-improved-immunogenicity-to-hiv-1-antigens-in-rhesus-macaques-compared-to-nonreplicating-nyvac/2019-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/safety-pharmacokinetics-and-immunogenicity-of-the-combination-of-the-broadly-neutralizing-anti-hiv-1-antibodies-3bnc117-and-10-1074-in-healthy-adults-a-randomized-phase-1-study/2019-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/semaphorin-7a-modulates-cytokine-induced-memory-like-responses-by-human-natural-killer-cells/2019-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/siv-infection-modulates-cd94klrd1-nk-cells-in-rhesus-macaques/2019-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/strong-th1-biased-cd4-t-cell-responses-are-associated-with-diminished-siv-vaccine-efficacy/2019-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/survey-of-bk-virus-screening-practices-by-american-society-of-transplantation-members/2019-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/the-landscape-of-persistent-viral-genomes-in-art-treated-siv-shiv-and-hiv-2-infections/2020-04-01T00:03:05-04:00https://cvvr.hms.harvard.edu/publication/vaccine-induction-of-antibodies-and-tissue-resident-cd8-t-cells-enhances-protection-against-mucosal-shiv-infection-in-young-macaques/2020-04-01T00:01:32-04:00https://cvvr.hms.harvard.edu/publication/vaccine-induced-protection-from-homologous-tier-2-shiv-challenge-in-nonhuman-primates-depends-on-serum-neutralizing-antibody-titers/2020-03-31T23:57:25-04:00https://cvvr.hms.harvard.edu/publication/a-cd4-mimetic-compound-enhances-vaccine-efficacy-against-stringent-immunodeficiency-virus-challenge/2018-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/a-single-injection-of-crystallizable-fragment-domain-modified-antibodies-elicits-durable-protection-from-shiv-infection/2018-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/adenoviral-vector-type-26-encoding-zika-virus-zikv-m-env-antigen-induces-humoral-and-cellular-immune-responses-and-protects-mice-and-nonhuman-primates-against-zikv-challenge/2020-04-01T00:11:13-04:00https://cvvr.hms.harvard.edu/publication/adenovirus-vector-vaccination-impacts-nk-cell-rheostat-function-following-lymphocytic-choriomeningitis-virus-infection/2020-04-01T00:10:39-04:00https://cvvr.hms.harvard.edu/publication/antibody-and-tlr7-agonist-delay-viral-rebound-in-shiv-infected-monkeys/2020-04-23T11:47:35-04:00https://cvvr.hms.harvard.edu/publication/antigen-specific-antibody-fc-glycosylation-enhances-humoral-immunity-via-the-recruitment-of-complement/2020-04-01T00:09:59-04:00https://cvvr.hms.harvard.edu/publication/capsid-cpsf6-interaction-licenses-nuclear-hiv-1-trafficking-to-sites-of-viral-dna-integration/2020-03-23T09:30:58-04:00https://cvvr.hms.harvard.edu/publication/cellular-and-molecular-mechanisms-of-hiv-1-integration-targeting/2020-03-23T09:30:58-04:00https://cvvr.hms.harvard.edu/publication/cmv-primes-functional-alternative-signaling-in-adaptive-%ce%b4g-nk-cells-but-is-subverted-by-lentivirus-infection-in-rhesus-macaques/2020-04-01T00:18:45-04:00https://cvvr.hms.harvard.edu/publication/co-formulation-of-broadly-neutralizing-antibodies-3bnc117-and-pgt121-analytical-challenges-during-pre-formulation-characterization-and-storage-stability-studies/2018-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/combination-therapy-with-anti-hiv-1-antibodies-maintains-viral-suppression/2018-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/combined-hdac-and-bet-inhibition-enhances-melanoma-vaccine-immunogenicity-and-efficacy/2020-04-01T00:31:54-04:00https://cvvr.hms.harvard.edu/publication/completeness-of-hiv-1-envelope-glycan-shield-at-transmission-determines-neutralization-breadth/2018-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/conformational-plasticity-in-broadly-neutralizing-hiv-1-antibodies-triggers-polyreactivity/2018-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/cytokine-mediated-tissue-injury-in-non-human-primate-models-of-viral-infections/2018-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/epitopes-for-neutralizing-antibodies-induced-by-hiv-1-envelope-glycoprotein-bg505-sosip-trimers-in-rabbits-and-macaques/2020-04-23T13:19:45-04:00https://cvvr.hms.harvard.edu/publication/evaluation-of-a-mosaic-hiv-1-vaccine-in-a-multicentre-randomised-double-blind-placebo-controlled-phase-1-2a-clinical-trial-approach-and-in-rhesus-monkeys-nhp-13-19/2020-03-18T11:09:10-04:00https://cvvr.hms.harvard.edu/publication/evidence-that-cd32a-does-not-mark-the-hiv-1-latent-reservoir/2020-03-18T15:18:21-04:00https://cvvr.hms.harvard.edu/publication/exosome-markers-associated-with-immune-activation-and-oxidative-stress-in-hiv-patients-on-antiretroviral-therapy/2018-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/exploiting-glycan-topography-for-computational-design-of-env-glycoprotein-antigenicity/2018-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/fetal-neuropathology-in-zika-virus-infected-pregnant-female-rhesus-monkeys/2020-04-23T13:31:48-04:00https://cvvr.hms.harvard.edu/publication/fine-epitope-signature-of-antibody-neutralization-breadth-at-the-hiv-1-envelope-cd4-binding-site/2018-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/first-in-human-randomized-controlled-trial-of-an-oral-replicating-adenovirus-26-vector-vaccine-for-hiv-1/2020-04-01T00:35:35-04:00https://cvvr.hms.harvard.edu/publication/first-in-human-randomized-controlled-trial-of-mosaic-hiv-1-immunogens-delivered-via-a-modified-vaccinia-ankara-vector/2020-04-01T00:38:14-04:00https://cvvr.hms.harvard.edu/publication/hallmarks-of-primate-lentiviral-immunodeficiency-infection-recapitulate-loss-of-innate-lymphoid-cells/2018-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/human-herpes-virus-8-in-hiv-1-infected-individuals-receiving-cancer-chemotherapy-and-stem-cell-transplantation/2018-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/identification-of-near-pan-neutralizing-antibodies-against-hiv-1-by-deconvolution-of-plasma-humoral-responses/2018-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/idlv-hiv-1-env-vaccination-in-non-human-primates-induces-affinity-maturation-of-antigen-specific-memory-b-cells/2018-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/immunogenicity-and-cross-reactivity-of-rhesus-adenoviral-vectors/2020-04-23T11:43:39-04:00https://cvvr.hms.harvard.edu/publication/immunogenicity-of-nyvac-prime-protein-boost-human-immunodeficiency-virus-type-1-envelope-vaccination-and-simian-human-immunodeficiency-virus-challenge-of-nonhuman-primates/2018-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/indirect-activation-of-rhesus-macaque-macaca-mulatta-nk-cells-in-oral-and-mucosal-draining-lymph-nodes/2018-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/initiation-of-antiviral-b-cell-immunity-relies-on-innate-signals-from-spatially-positioned-nkt-cells/2020-04-23T11:44:27-04:00https://cvvr.hms.harvard.edu/publication/intestinal-damage-precedes-mucosal-immune-dysfunction-in-siv-infection/2018-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/ledgf-p75-is-dispensable-for-hematopoiesis-but-essential-for-mll-rearranged-leukemogenesis/2020-03-23T09:30:58-04:00https://cvvr.hms.harvard.edu/publication/lymph-node-cellular-and-viral-dynamics-in-natural-hosts-and-impact-for-hiv-cure-strategies/2018-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/mucosal-antibody-responses-to-vaccines-targeting-siv-protease-cleavage-sites-or-full-length-gag-and-env-proteins-in-mauritian-cynomolgus-macaques/2018-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/neutralization-tiers-of-hiv-1/2018-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/neutralizing-activity-of-broadly-neutralizing-anti-hiv-1-antibodies-against-clade-b-clinical-isolates-produced-in-peripheral-blood-mononuclear-cells/2018-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/neutralizing-antibody-responses-following-long-term-vaccination-with-hiv-1-env-gp140-in-guinea-pigs/2020-04-23T11:44:59-04:00https://cvvr.hms.harvard.edu/publication/nk-cell-activation-is-associated-with-increased-hiv-transcriptional-activity-following-allogeneic-hematopoietic-cell-transplantation/2018-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/nl-preliminary-aggregate-safety-and-immunogenicity-results-from-three-trials-of-a-purified-inactivated-zika-virus-vaccine-candidate-phase-1-randomised-double-blind-placebo-controlled-clinical-tri/2018-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/optimization-and-qualification-of-an-fc-array-assay-for-assessments-of-antibodies-against-hiv-1-siv/2020-04-23T11:45:28-04:00https://cvvr.hms.harvard.edu/publication/persistence-of-endothelial-thrombomodulin-in-a-patient-with-infectious-purpura-fulminans-treated-with-protein-c-concentrate/2018-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/potential-of-conventional-bispecific-broadly-neutralizing-antibodies-for-prevention-of-hiv-1-subtype-a-c-d-infections/2020-04-23T11:45:50-04:00https://cvvr.hms.harvard.edu/publication/preliminary-aggregate-safety-and-immunogenicity-results-from-three-trials-of-a-purified-inactivated-zika-virus-vaccine-candidate-phase-1-randomised-double-blind-placebo-controlled-clinical-trials/2020-04-23T11:46:17-04:00https://cvvr.hms.harvard.edu/publication/prevention-of-sivmac251-reservoir-seeding-in-rhesus-monkeys-by-early-antiretroviral-therapy/2020-04-23T13:18:29-04:00https://cvvr.hms.harvard.edu/publication/progressive-lentivirus-infection-induces-natural-killer-cell-receptor-expressing-b-cells-in-the-gastrointestinal-tract/2018-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/rapid-cloning-of-novel-rhesus-adenoviral-vaccine-vectors/2020-04-23T13:16:51-04:00https://cvvr.hms.harvard.edu/publication/rational-zika-vaccine-design-via-the-modulation-of-antigen-membrane-anchors-in-chimpanzee-adenoviral-vectors/2020-04-23T13:16:20-04:00https://cvvr.hms.harvard.edu/publication/relationship-between-latent-and-rebound-viruses-in-a-clinical-trial-of-anti-hiv-1-antibody-3bnc117/2018-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/safety-and-antiviral-activity-of-combination-hiv-1-broadly-neutralizing-antibodies-in-viremic-individuals/2018-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/short-communication-apoptotic-membrane-microparticles-quantified-by-fluorescent-bead-based-assay-are-elevated-in-hiv-and-siv-infections/2018-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/similar-epitope-specificities-of-igg-and-iga-antibodies-elicited-by-ad26-vector-prime-env-protein-boost-immunizations-in-rhesus-monkeys/2020-04-23T13:15:39-04:00https://cvvr.hms.harvard.edu/publication/structure-of-the-membrane-proximal-external-region-of-hiv-1-envelope-glycoprotein/2018-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/t-cell-subset-differentiation-and-antibody-responses-following-antiretroviral-therapy-during-simian-immunodeficiency-virus-infection/2020-04-23T12:12:02-04:00https://cvvr.hms.harvard.edu/publication/the-human-il-15-superagonist-alt-803-directs-siv-specific-cd8-t-cells-into-b-cell-follicles/2018-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/therapeutic-and-protective-efficacy-of-a-dengue-antibody-against-zika-infection-in-rhesus-monkeys/2020-04-23T12:09:49-04:00https://cvvr.hms.harvard.edu/publication/therapeutic-efficacy-of-vectored-pgt121-gene-delivery-in-hiv-1-infected-humanized-mice/2020-04-23T12:01:48-04:00https://cvvr.hms.harvard.edu/publication/therapeutic-vaccination-for-hiv-hopes-and-challenges/2018-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/tlr7-agonists-induce-transient-viremia-and-reduce-the-viral-reservoir-in-siv-infected-rhesus-macaques-on-antiretroviral-therapy/2018-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/tracking-klrc2nkg2c-memory-and-memory-like-nk-cells-in-rhcmv-and-siv-rhesus-macaques/2018-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/zika-virus-research-models/2018-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/zika-virus-vaccines/2018-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/a-mouse-model-for-hcv-infection-are-we-there-yet/2017-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/a-supramolecular-assembly-mediates-lentiviral-dna-integration/2020-03-23T09:30:58-04:00https://cvvr.hms.harvard.edu/publication/adenovirus-prime-env-protein-boost-vaccine-protects-against-neutralization-resistant-sivsme660-variants-in-rhesus-monkeys/2020-04-23T13:22:00-04:00https://cvvr.hms.harvard.edu/publication/an-immunogenic-personal-neoantigen-vaccine-for-patients-with-melanoma/2020-04-23T13:21:25-04:00https://cvvr.hms.harvard.edu/publication/antibody-10-1074-suppresses-viremia-in-hiv-1-infected-individuals/2017-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/antigenicity-defined-conformations-of-an-extremely-neutralization-resistant-hiv-1-envelope-spike/2017-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/asymmetric-recognition-of-hiv-1-envelope-trimer-by-v1v2-loop-targeting-antibodies/2017-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/boosting-of-hiv-envelope-cd4-binding-site-antibodies-with-long-variable-heavy-third-complementary-determining-region-in-the-randomized-double-blind-rv305-hiv-1-vaccine-trial/2017-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/broadly-neutralizing-antibodies-suppress-post-transcytosis-hiv-1-infectivity/2017-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/broadly-neutralizing-antibodies-targeting-the-hiv-1-envelope-v2-apex-confer-protection-against-a-clade-c-shiv-challenge/2020-04-23T13:36:37-04:00https://cvvr.hms.harvard.edu/publication/capsid-dependent-host-factors-in-hiv-1-infection/2020-03-23T09:30:58-04:00https://cvvr.hms.harvard.edu/publication/coexistence-of-potent-hiv-1-broadly-neutralizing-antibodies-and-antibody-sensitive-viruses-in-a-viremic-controller/2017-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/cryo-em-structure-of-mxb-reveals-a-novel-oligomerization-interface-critical-for-hiv-restriction/2020-03-23T09:30:58-04:00https://cvvr.hms.harvard.edu/publication/development-of-novel-replication-defective-lymphocytic-choriomeningitis-virus-vectors-expressing-siv-antigens/2020-04-23T13:35:57-04:00https://cvvr.hms.harvard.edu/publication/durability-and-correlates-of-vaccine-protection-against-zika-virus-in-rhesus-monkeys/2020-04-23T13:35:05-04:00https://cvvr.hms.harvard.edu/publication/early-antibody-therapy-can-induce-long-lasting-immunity-to-shiv/2017-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/elicitation-of-robust-tier-2-neutralizing-antibody-responses-in-nonhuman-primates-by-hiv-envelope-trimer-immunization-using-optimized-approaches/2020-04-23T13:34:40-04:00https://cvvr.hms.harvard.edu/publication/hematopoietic-stem-and-progenitor-cells-from-human-pluripotent-stem-cells/2020-03-23T09:30:58-04:00https://cvvr.hms.harvard.edu/publication/hepatic-immunopathology-during-occult-hepacivirus-re-infection/2017-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/hiv-1-mediated-downmodulation-of-hla-c-impacts-target-cell-recognition-and-antiviral-activity-of-nk-cells/2017-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/hiv-aids-vaccine-candidates-based-on-replication-competent-recombinant-poxvirus-nyvac-c-kc-expressing-trimeric-gp140-and-gag-derived-vlps-or-lacking-the-viral-molecule-b19-that-inhibits-type-i-interfe/2017-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/human-immunodeficiency-virus-type-1-persistence-following-systemic-chemotherapy-for-malignancy/2017-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/impact-of-prior-flavivirus-immunity-on-zika-virus-infection-in-rhesus-macaques/2020-04-23T13:34:03-04:00https://cvvr.hms.harvard.edu/publication/inhibition-of-hiv-1-maturation-via-small-molecule-targeting-of-the-amino-terminal-domain-in-the-viral-capsid-protein/2020-03-23T09:30:58-04:00https://cvvr.hms.harvard.edu/publication/initiation-of-hiv-neutralizing-b-cell-lineages-with-sequential-envelope-immunizations/2017-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/innate-lymphoid-cells-in-hiv-siv-infections/2017-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/mauritian-cynomolgus-macaques-with-m3m4-mhc-genotype-control-sivmac251-infection/2017-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/metabolic-dysregulation-in-hepacivirus-infection-of-common-marmosets-callithrix-jacchus/2017-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/molecular-mechanisms-for-cfim-mediated-regulation-of-mrna-alternative-polyadenylation/2020-03-23T09:30:58-04:00https://cvvr.hms.harvard.edu/publication/multiplex-single-cell-visualization-of-nucleic-acids-and-protein-during-hiv-infection/2020-03-23T09:30:58-04:00https://cvvr.hms.harvard.edu/publication/multiplexed-fc-array-for-evaluation-of-antigen-specific-antibody-effector-profiles/2020-04-23T13:33:38-04:00https://cvvr.hms.harvard.edu/publication/natural-and-cross-inducible-anti-siv-antibodies-in-mauritian-cynomolgus-macaques/2017-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/natural-killer-cells-migrate-into-and-control-simian-immunodeficiency-virus-replication-in-lymph-node-follicles-in-african-green-monkeys/2017-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/non-neutralizing-antibodies-alter-the-course-of-hiv-1-infection-in-vivo/2017-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/nonhuman-primate-models-of-zika-virus-infection-immunity-and-therapeutic-development/2017-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/panels-of-hiv-1-subtype-c-env-reference-strains-for-standardized-neutralization-assessments/2017-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/potent-and-broad-hiv-neutralizing-antibodies-in-memory-b-cells-and-plasma/2017-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/pre-transplant-immune-factors-may-be-associated-with-bk-polyomavirus-reactivation-in-kidney-transplant-recipients/2017-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/protection-against-a-mixed-shiv-challenge-by-a-broadly-neutralizing-antibody-cocktail/2020-04-23T13:33:10-04:00https://cvvr.hms.harvard.edu/publication/protective-efficacy-of-broadly-neutralizing-antibodies-with-incomplete-neutralization-activity-against-shiv-in-rhesus-monkeys/2020-04-23T13:27:01-04:00https://cvvr.hms.harvard.edu/publication/reactivation-of-multiple-infectious-pathogens-after-hematopoietic-stem-cell-transplantation/2017-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/redefining-memory-building-the-case-for-adaptive-nk-cells/2017-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/regulation-of-cd4-t-cells-and-their-effects-on-immunopathological-inflammation-following-viral-infection/2020-04-23T13:26:15-04:00https://cvvr.hms.harvard.edu/publication/resistance-to-pyridine-based-inhibitor-kf116-reveals-an-unexpected-role-of-integrase-in-hiv-1-gag-pol-proteolytic-processing/2020-03-23T09:30:58-04:00https://cvvr.hms.harvard.edu/publication/retroviral-intasomes-arising/2020-03-23T09:30:58-04:00https://cvvr.hms.harvard.edu/publication/retroviral-integrase-protein-and-intasome-nucleoprotein-complex-structures/2020-03-23T09:30:58-04:00https://cvvr.hms.harvard.edu/publication/statoviruses-a-novel-taxon-of-rna-viruses-present-in-the-gastrointestinal-tracts-of-diverse-mammals/2020-04-23T13:25:35-04:00https://cvvr.hms.harvard.edu/publication/structural-basis-for-spumavirus-gag-tethering-to-chromatin/2020-03-23T09:30:58-04:00https://cvvr.hms.harvard.edu/publication/trispecific-broadly-neutralizing-hiv-antibodies-mediate-potent-shiv-protection-in-macaques/2020-04-23T13:24:33-04:00https://cvvr.hms.harvard.edu/publication/vaccine-elicitation-of-high-mannose-dependent-neutralizing-antibodies-against-the-v3-glycan-broadly-neutralizing-epitope-in-nonhuman-primates/2020-04-23T13:25:11-04:00https://cvvr.hms.harvard.edu/publication/vaccine-induction-of-heterologous-tier-2-hiv-1-neutralizing-antibodies-in-animal-models/2017-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/virological-control-by-the-cd4-binding-site-antibody-n6-in-simian-human-immunodeficiency-virus-infected-rhesus-monkeys/2020-04-23T13:24:01-04:00https://cvvr.hms.harvard.edu/publication/virus-driven-inflammation-is-associated-with-the-development-of-bnabs-in-spontaneous-controllers-of-hiv/2017-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/virusseeker-a-computational-pipeline-for-virus-discovery-and-virome-composition-analysis/2020-04-23T13:22:34-04:00https://cvvr.hms.harvard.edu/publication/zika-plasma-viral-dynamics-in-nonhuman-primates-provides-insights-into-early-infection-and-antiviral-strategies/2017-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/zika-virus-persistence-in-the-central-nervous-system-and-lymph-nodes-of-rhesus-monkeys/2020-04-23T13:32:23-04:00https://cvvr.hms.harvard.edu/publication/a-critical-role-for-alternative-polyadenylation-factor-cpsf6-in-targeting-hiv-1-integration-to-transcriptionally-active-chromatin/2020-03-23T09:30:58-04:00https://cvvr.hms.harvard.edu/publication/a-new-class-of-allosteric-hiv-1-integrase-inhibitors-identified-by-crystallographic-fragment-screening-of-the-catalytic-core-domain/2020-03-23T09:30:58-04:00https://cvvr.hms.harvard.edu/publication/a-new-glycan-dependent-cd4-binding-site-neutralizing-antibody-exerts-pressure-on-hiv-1-in-vivo/2016-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/a-subset-of-latency-reversing-agents-expose-hiv-infected-resting-cd4-t-cells-to-recognition-by-cytotoxic-t-lymphocytes/2016-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/acute-liver-damage-associated-with-innate-immune-activation-in-a-small-nonhuman-primate-model-of-hepacivirus-infection/2016-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/ad26-mva-therapeutic-vaccination-with-tlr7-stimulation-in-siv-infected-rhesus-monkeys/2020-03-20T15:04:57-04:00https://cvvr.hms.harvard.edu/publication/adenovirus-serotype-5-vaccine-vectors-trigger-il-27-dependent-inhibitory-cd4-t-cell-responses-that-impair-cd8-t-cell-function/2020-04-23T13:43:21-04:00https://cvvr.hms.harvard.edu/publication/allosteric-hiv-1-integrase-inhibitors-promote-aberrant-protein-multimerization-by-directly-mediating-inter-subunit-interactions-structural-and-thermodynamic-modeling-studies/2020-03-23T09:30:58-04:00https://cvvr.hms.harvard.edu/publication/amplification-next-generation-sequencing-and-genomic-dna-mapping-of-retroviral-integration-sites/2020-03-23T09:30:58-04:00https://cvvr.hms.harvard.edu/publication/anti-hiv-1-antibody-3bnc117-suppresses-rebound-in-humans-during-treatment-interruption/2016-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/antibodies-elicited-by-multiple-envelope-glycoprotein-immunogens-in-primates-neutralize-primary-human-immunodeficiency-viruses-hiv-1-sensitized-by-cd4-mimetic-compounds/2016-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/antibody-responses-after-analytic-treatment-interruption-in-human-immunodeficiency-virus-1-infected-individuals-on-early-initiated-antiretroviral-therapy/2020-04-23T13:45:00-04:00https://cvvr.hms.harvard.edu/publication/antibody-mediated-protection-against-shiv-challenge-includes-systemic-clearance-of-distal-virus/2020-03-18T14:53:27-04:00https://cvvr.hms.harvard.edu/publication/antigen-specific-antibody-glycosylation-is-regulated-via-vaccination/2020-04-23T13:46:59-04:00https://cvvr.hms.harvard.edu/publication/assessment-of-the-safety-and-immunogenicity-of-2-novel-vaccine-platforms-for-hiv-1-prevention-a-randomized-trial/2020-04-23T13:46:32-04:00https://cvvr.hms.harvard.edu/publication/bispecific-anti-hiv-antibodies-with-enhanced-breadth-and-potency/2016-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/broadly-neutralizing-antibodies-for-hiv-eradication/2016-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/capsid-cpsf6-interaction-is-dispensable-for-hiv-1-replication-in-primary-cells-but-is-selected-during-virus-passage-in-vivo/2020-03-23T09:30:58-04:00https://cvvr.hms.harvard.edu/publication/comparative-immunogenicity-of-hiv-1-gp140-vaccine-delivered-by-parenteral-and-mucosal-routes-in-female-volunteers-mucovac2-a-randomized-two-centre-study/2016-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/cryo-em-reveals-a-novel-octameric-integrase-structure-for-betaretroviral-intasome-function/2020-03-23T09:30:58-04:00https://cvvr.hms.harvard.edu/publication/distinct-hiv-1-neutralization-potency-profiles-of-ibalizumab-based-bispecific-antibodies/2016-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/effects-of-fecal-microbial-transplantation-on-microbiome-and-immunity-in-simian-immunodeficiency-virus-infected-macaques/2016-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/elucidating-the-target-of-hiv-1-active-and-passive-immunization-studies-features-of-recently-transmitted-hiv-1-clade-c-viruses-that-impact-antibody-recognition/2016-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/engineered-bispecific-antibodies-with-exquisite-hiv-1-neutralizing-activity/2016-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/engineered-murine-hscs-reconstitute-multi-lineage-hematopoiesis-and-adaptive-immunity/2020-03-23T09:30:58-04:00https://cvvr.hms.harvard.edu/publication/enhancement-of-microbiota-in-healthy-macaques-results-in-beneficial-modulation-of-mucosal-and-systemic-immune-function/2016-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/envelope-residue-375-substitutions-in-simian-human-immunodeficiency-viruses-enhance-cd4-binding-and-replication-in-rhesus-macaques/2016-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/establishment-and-reversal-of-hiv-1-latency-in-naive-and-central-memory-cd4-t-cells-in-vitro/2020-03-23T09:30:59-04:00https://cvvr.hms.harvard.edu/publication/fc-receptor-mediated-activities-of-env-specific-human-monoclonal-antibodies-generated-from-volunteers-receiving-the-dna-prime-protein-boost-hiv-vaccine-dp6-001/2016-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/heterozygosity-hiv-1-reservoir-size-and-lymphocyte-activation-in-individuals-receiving-long-term-suppressive-antiretroviral-therapy/2016-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/hiv-1-antibody-neutralization-breadth-is-associated-with-enhanced-hiv-specific-cd4-t-cell-responses/2016-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/hiv-1-therapy-with-monoclonal-antibody-3bnc117-elicits-host-immune-responses-against-hiv-1/2016-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/hyperexpansion-of-rna-bacteriophage-diversity/2020-04-23T13:48:04-04:00https://cvvr.hms.harvard.edu/publication/identification-of-a-cd4-binding-site-antibody-to-hiv-that-evolved-near-pan-neutralization-breadth/2016-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/immediate-dysfunction-of-vaccine-elicited-cd8-t-cells-primed-in-the-absence-of-cd4-t-cells/2020-04-23T13:49:08-04:00https://cvvr.hms.harvard.edu/publication/immunization-of-hiv-1-infected-persons-with-autologous-dendritic-cells-transfected-with-mrna-encoding-hiv-1-gag-and-nef-results-of-a-randomized-placebo-controlled-clinical-trial/2020-04-23T13:50:45-04:00https://cvvr.hms.harvard.edu/publication/increased-frequencies-of-cd8cd57-t-cells-are-associated-with-antibody-neutralization-breadth-against-hiv-in-viraemic-controllers/2016-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/inhibitory-receptor-expression-on-memory-cd8-t-cells-following-ad-vector-immunization/2020-04-23T13:37:10-04:00https://cvvr.hms.harvard.edu/publication/interactions-of-prototype-foamy-virus-capsids-with-host-polo-like-kinases-are-important-for-efficient-viral-dna-integration/2020-03-23T09:30:59-04:00https://cvvr.hms.harvard.edu/publication/lambda-light-chain-bias-associated-with-enhanced-binding-and-function-of-anti-hiv-env-glycoprotein-antibodies/2016-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/natively-glycosylated-hiv-1-env-structure-reveals-new-mode-for-antibody-recognition-of-the-cd4-binding-site/2016-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/naturally-occurring-subclinical-endotoxemia-in-humans-alters-adaptive-and-innate-immune-functions-through-reduced-mapk-and-increased-stat1-phosphorylation/2016-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/neutralizing-antibody-affords-comparable-protection-against-vaginal-and-rectal-shiv-challenge-in-macaques/2020-04-23T13:37:47-04:00https://cvvr.hms.harvard.edu/publication/new-concepts-in-hiv-1-vaccine-development/2016-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/open-conformers-of-hla-f-are-high-affinity-ligands-of-the-activating-nk-cell-receptor-kir3ds1/2016-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/optimal-combinations-of-broadly-neutralizing-antibodies-for-prevention-and-treatment-of-hiv-1-clade-c-infection/2020-04-23T13:38:18-04:00https://cvvr.hms.harvard.edu/publication/paired-quantitative-and-qualitative-assessment-of-the-replication-competent-hiv-1-reservoir-and-comparison-with-integrated-proviral-dna/2016-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/persistent-low-level-replication-of-siv%e2%88%86nef-drives-maturation-of-antibody-and-cd8-t-cell-responses-to-induce-protective-immunity-against-vaginal-siv-infection/2016-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/production-of-mucosally-transmissible-shiv-challenge-stocks-from-hiv-1-circulating-recombinant-form-01_ae-env-sequences/2020-04-23T13:39:46-04:00https://cvvr.hms.harvard.edu/publication/protective-efficacy-of-multiple-vaccine-platforms-against-zika-virus-challenge-in-rhesus-monkeys/2020-03-18T14:53:04-04:00https://cvvr.hms.harvard.edu/publication/rapid-development-of-a-dna-vaccine-for-zika-virus/2020-04-23T13:41:09-04:00https://cvvr.hms.harvard.edu/publication/rapid-inflammasome-activation-following-mucosal-siv-infection-of-rhesus-monkeys/2020-04-23T11:53:17-04:00https://cvvr.hms.harvard.edu/publication/retroviral-dna-integration/2020-03-23T09:30:59-04:00https://cvvr.hms.harvard.edu/publication/roles-of-capsid-interacting-host-factors-in-multimodal-inhibition-of-hiv-1-by-pf74/2020-03-23T09:30:58-04:00https://cvvr.hms.harvard.edu/publication/siv-infection-mediated-changes-in-gastrointestinal-bacterial-microbiome-and-virome-are-associated-with-immunodeficiency-and-prevented-by-vaccination/2020-04-23T13:41:41-04:00https://cvvr.hms.harvard.edu/publication/siv-induced-translocation-of-bacterial-products-in-the-liver-mobilizes-myeloid-dendritic-and-natural-killer-cells-associated-with-liver-damage/2016-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/small-molecule-cd4-mimics-structure-based-optimization-of-hiv-1-entry-inhibition/2016-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/specifically-modified-env-immunogens-activate-b-cell-precursors-of-broadly-neutralizing-hiv-1-antibodies-in-transgenic-mice/2016-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/streamlining-heterologous-dna-prime-and-nyvac-protein-boost-hiv-vaccine-regimens-in-rhesus-macaques-by-employing-improved-antigens/2016-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/strong-but-age-dependent-protection-elicited-by-a-deoxyribonucleic-acid-modified-vaccinia-ankara-simian-immunodeficiency-virus-vaccine/2016-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/structural-basis-for-membrane-anchoring-of-hiv-1-envelope-spike/2016-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/structural-constraints-of-vaccine-induced-tier-2-autologous-hiv-neutralizing-antibodies-targeting-the-receptor-binding-site/2016-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/structure-function-studies-involving-the-v3-region-of-the-hiv-1-envelope-delineate-multiple-factors-that-affect-neutralization-sensitivity/2016-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/the-cleavage-and-polyadenylation-specific-factor-6-cpsf6-subunit-of-the-capsid-recruited-pre-messenger-rna-cleavage-factor-i-cfim-complex-mediates-hiv-1-integration-into-genes/2020-03-23T09:30:58-04:00https://cvvr.hms.harvard.edu/publication/the-competitive-interplay-between-allosteric-hiv-1-integrase-inhibitor-bi-d-and-ledgf-p75-during-the-early-stage-of-hiv-1-replication-adversely-affects-inhibitor-potency/2020-03-23T09:30:58-04:00https://cvvr.hms.harvard.edu/publication/transient-cd4-t-cell-depletion-results-in-the-delayed-development-of-functional-vaccine-elicited-antibody-responses/2020-04-23T13:42:15-04:00https://cvvr.hms.harvard.edu/publication/vaccination-with-heterologous-hiv-1-envelope-sequences-and-heterologous-adenovirus-vectors-increases-t-cell-responses-to-conserved-regions-hvtn-083/2016-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/vaccine-protection-against-zika-virus-from-brazil/2020-03-18T11:05:17-04:00https://cvvr.hms.harvard.edu/publication/zika-viral-dynamics-and-shedding-in-rhesus-and-cynomolgus-macaques/2020-03-18T11:07:31-04:00https://cvvr.hms.harvard.edu/publication/a-broad-range-of-mutations-in-hiv-1-neutralizing-human-monoclonal-antibodies-specific-for-v2-v3-and-the-cd4-binding-site/2015-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/a-method-for-high-throughput-sensitive-analysis-of-igg-fc-and-fab-glycosylation-by-capillary-electrophoresis/2015-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/a-multivalent-clade-c-hiv-1-env-trimer-cocktail-elicits-a-higher-magnitude-of-neutralizing-antibodies-than-any-individual-component/2015-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/aav-expressed-ecd4-ig-provides-durable-protection-from-multiple-shiv-challenges/2015-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/accumulation-of-cytotoxic-cd16-nk-cells-in-simian-immunodeficiency-virus-infected-lymph-nodes-associated-with-in-situ-differentiation-and-functional-anergy/2015-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/antigen-specific-nk-cell-memory-in-rhesus-macaques/2020-03-18T11:06:48-04:00https://cvvr.hms.harvard.edu/publication/attenuation-of-replication-competent-adenovirus-serotype-26-vaccines-by-vectorization/2015-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/bk-polyomavirus-reactivation-after-reduced-intensity-double-umbilical-cord-blood-cell-transplantation/2015-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/bone-marrow-imprinted-gut-homing-of-plasmacytoid-dendritic-cells-pdcs-in-acute-simian-immunodeficiency-virus-infection-results-in-massive-accumulation-of-hyperfunctional-cd4-pdcs-in-the-mucosae/2015-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/cd4-t-cell-depletion-substantially-augments-the-rescue-potential-of-pd-l1-blockade-for-deeply-exhausted-cd8-t-cells/2015-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/cd8-t-cell-response-maturation-defined-by-anentropic-specificity-and-repertoire-depth-correlates-with-sivdnef-induced-protection/2015-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/characterization-of-cd8-t-cell-differentiation-following-sivdnef-vaccination-by-transcription-factor-expression-profiling/2015-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/comparison-of-immunogenicity-in-rhesus-macaques-of-transmitted-founder-hiv-1-group-m-consensus-and-trivalent-mosaic-envelope-vaccines-formulated-as-a-dna-prime-nyvac-and-envelope-protein-boost/2015-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/construction-and-evaluation-of-novel-rhesus-monkey-adenovirus-vaccine-vectors/2015-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/dissecting-polyclonal-vaccine-induced-humoral-immunity-against-hiv-using-systems-serology/2015-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/distribution-and-redistribution-of-hiv-1-nucleocapsid-protein-in-immature-mature-and-integrase-inhibited-virions-a-role-for-integrase-in-maturation/2020-03-23T09:30:59-04:00https://cvvr.hms.harvard.edu/publication/effect-of-the-cytoplasmic-domain-on-antigenic-characteristics-of-hiv-1-envelope-glycoprotein/2015-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/embryonic-lethality-due-to-arrested-cardiac-development-in-psip1-hdgfrp2-double-deficient-mice/2020-03-23T09:30:59-04:00https://cvvr.hms.harvard.edu/publication/foreign-dna-capture-during-crispr-cas-adaptive-immunity/2020-03-23T09:30:59-04:00https://cvvr.hms.harvard.edu/publication/functional-and-structural-characterization-of-human-v3-specific-monoclonal-antibody-2424-with-neutralizing-activity-against-hiv-1-jrfl/2015-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/glycan-dependent-neutralizing-antibodies-are-frequently-elicited-in-individuals-chronically-infected-with-hiv-1-clade-b-or-c/2015-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/hiv-1-vaccines-hiv-1-neutralizing-antibodies-induced-by-native-like-envelope-trimers/2015-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/human-non-neutralizing-hiv-1-envelope-monoclonal-antibodies-limit-the-number-of-founder-viruses-during-shiv-mucosal-infection-in-rhesus-macaques/2015-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/immunization-for-hiv-1-broadly-neutralizing-antibodies-in-human-ig-knockin-mice/2015-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/impact-of-hmg-coa-reductase-inhibitors-on-the-incidence-of-polyomavirus-associated-nephropathy-in-renal-transplant-recipients-with-human-bk-polyomavirus-viremia/2015-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/incomplete-neutralization-and-deviation-from-sigmoidal-neutralization-curves-for-hiv-broadly-neutralizing-monoclonal-antibodies/2015-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/induction-of-hiv-1-specific-mucosal-immune-responses-following-intramuscular-recombinant-adenovirus-serotype-26-hiv-1-vaccination-of-humans/2015-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/influence-of-glycosylation-inhibition-on-the-binding-of-kir3dl1-to-hla-b5701/2015-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/integrase-mediated-spacer-acquisition-during-crispr-cas-adaptive-immunity/2020-03-23T09:30:59-04:00https://cvvr.hms.harvard.edu/publication/intra-spike-crosslinking-overcomes-antibody-evasion-by-hiv-1/2015-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/key-determinants-of-target-dna-recognition-by-retroviral-intasomes/2020-03-23T09:30:59-04:00https://cvvr.hms.harvard.edu/publication/nk-cell-exhaustion-bad-news-for-chronic-disease/2015-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/programmed-cell-death-1-and-helios-distinguish-tcr-%ce%b1%ce%b2-double-negative-cd4-cd8-t-cells-that-derive-from-self-reactive-cd8-t-cells/2015-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/protective-efficacy-of-adenovirus-protein-vaccines-against-siv-challenges-in-rhesus-monkeys/2020-03-18T15:16:35-04:00https://cvvr.hms.harvard.edu/publication/quantification-of-the-epitope-diversity-of-hiv-1-specific-binding-antibodies-by-peptide-microarrays-for-global-hiv-1-vaccine-development/2015-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/sites-of-retroviral-dna-integration-from-basic-research-to-clinical-applications/2020-03-23T09:30:59-04:00https://cvvr.hms.harvard.edu/publication/structural-basis-for-retroviral-integration-into-nucleosomes/2020-03-23T09:30:59-04:00https://cvvr.hms.harvard.edu/publication/targeting-the-gastrointestinal-tract-to-develop-novel-therapies-for-hiv/2015-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/vaccine-elicited-cd4-t-cells-induce-immunopathology-following-chronic-lcmv-infection/2015-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/viraemia-suppressed-in-hiv-1-infected-humans-by-broadly-neutralizing-antibody-3bnc117/2015-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/a-fusion-intermediate-gp41-immunogen-elicits-neutralizing-antibodies-to-hiv-1/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/a-nonhuman-primate-toxicology-and-immunogenicity-study-evaluating-aerosol-delivery-of-aeras-402-ad35-vaccine-evidence-for-transient-t-cell-responses-in-peripheral-blood-and-robust-sustained-responses/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/adenovirus-serotype-26-and-35-vectors-induce-simian-immunodeficiency-virus-specific-t-lymphocyte-responses-in-foreskin-in-rhesus-monkeys/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/antibody-8anc195-reveals-a-site-of-broad-vulnerability-on-the-hiv-1-envelope-spike/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/antibody-light-chain-restricted-recognition-of-the-site-of-immune-pressure-in-the-rv144-hiv-1-vaccine-trial-is-phylogenetically-conserved/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/augmented-replicative-capacity-of-the-boosting-antigen-improves-the-protective-efficacy-of-heterologous-prime-boost-vaccine-regimens/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/broadly-neutralizing-anti-hiv-1-antibodies-require-fc-effector-functions-for-in-vivo-activity/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/broadly-neutralizing-hiv-antibodies-define-a-glycan-dependent-epitope-on-the-prefusion-conformation-of-gp41-on-cleaved-envelope-trimers/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/cd4-t-cell-help-enhances-nk-cell-function-following-therapeutic-hiv-1-vaccination/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/characterization-and-immunogenicity-of-a-novel-mosaic-m-hiv-1-gp140-trimer/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/common-features-of-mucosal-and-peripheral-antibody-responses-elicited-by-candidate-hiv-1-vaccines-in-rhesus-monkeys/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/comparison-of-multiple-adjuvants-on-the-stability-and-immunogenicity-of-a-clade-c-hiv-1-gp140-trimer/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/cross-reactive-potential-of-human-t-lymphocyte-responses-in-hiv-1-infection/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/das181-treatment-of-hematopoietic-stem-cell-transplant-patients-with-parainfluenza-virus-lung-disease-requiring-mechanical-ventilation/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/depletion-of-lamina-propria-innate-lymphoid-cells-in-simian-immunodeficiency-virus-infection/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/design-of-lipid-nanocapsule-delivery-vehicles-for-multivalent-display-of-recombinant-env-trimers-in-hiv-vaccination/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/disruption-of-helix-capping-residues-671-and-674-reveals-a-role-in-hiv-1-entry-for-a-specialized-hinge-segment-of-the-membrane-proximal-external-region-of-gp41/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/efficient-transduction-of-ledgf-p75-mutant-cells-by-complementary-gain-of-function-hiv-1-integrase-mutant-viruses/2020-03-23T09:30:59-04:00https://cvvr.hms.harvard.edu/publication/engineered-hyperactive-integrase-for-concerted-hiv-1-dna-integration/2020-03-23T09:30:59-04:00https://cvvr.hms.harvard.edu/publication/enhanced-hiv-1-immunotherapy-by-commonly-arising-antibodies-that-target-the-trimer-apex/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/enhanced-immune-activation-linked-to-endotoxemia-in-hiv-1-seronegative-msm/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/enhanced-immunogenicity-of-an-hiv-1-dna-vaccine-delivered-with-electroporation-via-combined-intramuscular-and-intradermal-routes/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/first-in-human-evaluation-of-a-hexon-chimeric-adenovirus-vector-expressing-hiv-1-ipcavd-002/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/generation-and-evaluation-of-clade-c-simian-human-immunodeficiency-virus-challenge-stocks/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/global-panel-of-hiv-1-env-reference-strains-for-standardized-assessments-of-vaccine-elicited-neutralizing-antibodies/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/hexon-hypervariable-region-modified-adenovirus-5-vectors-display-reduced-hepatotoxicity-but-induce-t-lymphocyte-phenotypes-similar-to-ad5-vectors/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/host-and-viral-determinants-for-mxb-restriction-of-hiv-1-infection/2020-03-23T09:30:59-04:00https://cvvr.hms.harvard.edu/publication/hypercytotoxicity-and-rapid-loss-of-nkp44-innate-lymphoid-cells-during-acute-siv-infection/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/immune-reconstitution-after-allogeneic-hematopoietic-stem-cell-transplantation-is-associated-with-selective-control-of-jc-virus-reactivation/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/impact-of-clade-geography-and-age-of-the-epidemic-on-hiv-1-neutralization-by-antibodies/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/increased-frequency-and-function-of-kir2dl1-3-nk-cells-in-primary-hiv-1-infection-are-determined-by-hla-c-group-haplotypes/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/infection-of-monkeys-by-simian-human-immunodeficiency-viruses-with-transmitted-founder-clade-c-hiv-1-envelopes/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/integrase-residues-that-determine-nucleotide-preferences-at-sites-of-hiv-1-integration-implications-for-the-mechanism-of-target-dna-binding/2020-03-23T09:30:59-04:00https://cvvr.hms.harvard.edu/publication/lack-of-protection-following-passive-transfer-of-polyclonal-highly-functional-low-dose-non-neutralizing-antibodies/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/late-endosomal-trafficking-of-alternative-serotype-adenovirus-vaccine-vectors-augments-antiviral-innate-immunity/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/live-simian-immunodeficiency-virus-vaccine-correlate-of-protection-local-antibody-production-and-concentration-on-the-path-of-virus-entry/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/longitudinal-requirement-for-cd4-t-cell-help-for-adenovirus-vector-elicited-cd8-t-cell-responses/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/mechanism-of-hiv-1-neutralization-by-antibodies-targeting-a-membrane-proximal-region-of-gp41/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/mechanisms-consequences-and-treatment-of-chronic-inflammation-in-hiv-disease/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/modeling-hcv-disease-in-animals-virology-immunology-and-pathogenesis-of-hcv-and-gbv-b-infections/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/molecular-evolution-of-broadly-neutralizing-llama-antibodies-to-the-cd4-binding-site-of-hiv-1/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/molecular-mechanisms-of-retroviral-integration-site-selection/2020-03-23T09:30:59-04:00https://cvvr.hms.harvard.edu/publication/neutralizing-antibodies-and-viral-inducers-decrease-rebound-from-hiv-1-latent-reservoirs-in-humanized-mice/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/nk-cell-responses-to-simian-immunodeficiency-virus-vaginal-exposure-in-naive-and-vaccinated-rhesus-macaques/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/optimization-and-validation-of-the-tzm-bl-assay-for-standardized-assessments-of-neutralizing-antibodies-against-hiv-1/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/prevalence-of-broadly-neutralizing-antibody-responses-during-chronic-hiv-1-infection/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/promiscuous-glycan-site-recognition-by-antibodies-to-the-high-mannose-patch-of-gp120-broadens-neutralization-of-hiv/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/rapid-seeding-of-the-viral-reservoir-prior-to-siv-viraemia-in-rhesus-monkeys/2020-03-18T11:06:00-04:00https://cvvr.hms.harvard.edu/publication/rational-design-and-characterization-of-the-novel-broad-and-potent-bispecific-hiv-1-neutralizing-antibody-imabm36/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/recombinant-hiv-envelope-trimer-selects-for-quaternary-dependent-antibodies-targeting-the-trimer-apex/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/retroviral-integrase-structure-and-dna-recombination-mechanism/2020-03-23T09:30:59-04:00https://cvvr.hms.harvard.edu/publication/short-communication-plasmacytoid-dendritic-cells-from-hiv-1-elite-controllers-maintain-a-gut-homing-phenotype-associated-with-immune-activation/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/specificity-and-6-month-durability-of-immune-responses-induced-by-dna-and-recombinant-modified-vaccinia-ankara-vaccines-expressing-hiv-1-virus-like-particles/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/structural-basis-for-nuclear-import-of-splicing-factors-by-human-transportin-3/2020-03-23T09:30:59-04:00https://cvvr.hms.harvard.edu/publication/structural-insight-into-hiv-1-restriction-by-mxb/2020-03-23T09:30:59-04:00https://cvvr.hms.harvard.edu/publication/the-canarypox-vector-alvac-induces-distinct-cytokine-responses-compared-to-the-vaccinia-based-vectors-mva-and-nyvac-in-rhesus-monkeys/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/the-immune-space-a-concept-and-template-for-rationalizing-vaccine-development/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/the-mechanism-of-h171t-resistance-reveals-the-importance-of-n%ce%b4-protonated-his171-for-the-binding-of-allosteric-inhibitor-bi-d-to-hiv-1-integrase/2020-03-23T09:30:59-04:00https://cvvr.hms.harvard.edu/publication/the-polyomavirus-puzzle-is-host-immune-response-beneficial-in-controlling-bk-virus-after-adult-hematopoietic-cell-transplantion/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/toll-like-receptor-7-8-tlr7-8-and-tlr9-agonists-cooperate-to-enhance-hiv-1-envelope-antibody-responses-in-rhesus-macaques/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/transcriptional-profiling-of-peripheral-cd8-t-cell-responses-to-sivdnef-and-sivmac251-challenge-reveals-a-link-between-protective-immunity-and-induction-of-systemic-immunoregulatory-mechanisms/2014-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/a-global-approach-to-hiv-1-vaccine-development/2013-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/a-gp41-mper-specific-llama-vhh-requires-a-hydrophobic-cdr3-for-neutralization-but-not-for-antigen-recognition/2013-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/a-novel-rabbit-monoclonal-antibody-platform-to-dissect-the-diverse-repertoire-of-antibody-epitopes-for-hiv-1-env-immunogen-design/2013-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/all-trans-retinoic-acid-imprints-expression-of-the-gut-homing-marker-a4b7-while-suppressing-lymph-node-homing-of-dendritic-cells/2013-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/allosteric-inhibition-of-hiv-1-integrase-activity/2020-03-23T09:30:59-04:00https://cvvr.hms.harvard.edu/publication/allosteric-integrase-potency-is-determined-through-the-inhibition-of-hiv-1-particle-maturation/2020-03-23T09:30:59-04:00https://cvvr.hms.harvard.edu/publication/alternative-serotype-adenovirus-vaccine-vectors-elicit-memory-t-cells-with-enhanced-anamnestic-capacity-compared-to-ad5-vectors/2013-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/an-attenuated-listeria-monocytogenes-vector-primes-more-potent-simian-immunodeficiency-virus-specific-mucosal-immunity-than-dna-vaccines-in-mice/2013-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/antibody-conjugation-approach-enhances-breadth-and-potency-of-neutralization-of-anti-hiv-1-antibodies-and-cd4-igg/2013-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/antibody-mediated-immunotherapy-of-macaques-chronically-infected-with-shiv-suppresses-viraemia/2013-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/antigenicity-and-immunogenicity-of-rv144-vaccine-aidsvax-clade-e-envelope-immunogen-is-enhanced-by-a-gp120-n-terminal-deletion/2013-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/biochemical-characterization-of-novel-retroviral-integrase-proteins/2020-03-23T09:30:59-04:00https://cvvr.hms.harvard.edu/publication/bispecific-antibodies-directed-to-cd4-domain-2-and-hiv-envelope-exhibit-exceptional-breadth-and-picomolar-potency-against-hiv-1/2013-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/characterization-of-circulating-natural-killer-cells-in-neotropical-primates/2013-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/characterization-of-humoral-and-cellular-immune-responses-elicited-by-a-recombinant-adenovirus-serotype-26-hiv-1-env-vaccine-in-healthy-adults-ipcavd-001/2013-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/comparative-analysis-of-siv-gag-specific-effector-and-memory-cd8-t-cells-induced-by-different-adenovirus-vectors/2013-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/comparative-characterization-of-transfection-and-infection-derived-simian-immunodeficiency-virus-challenge-stocks-for-in-vivo-nonhuman-primate-studies/2013-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/computational-prediction-of-broadly-neutralizing-hiv-1-antibody-epitopes-from-neutralization-activity-data/2013-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/cross-neutralizing-activity-of-human-anti-v3-monoclonal-antibodies-derived-from-non-clade-b-hiv-1-infected-individuals/2013-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/csf-viral-escape-in-a-patient-with-hiv-associated-neurocognitive-disorder/2013-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/detection-of-jc-virus-specific-immune-responses-in-a-novel-humanized-mouse-model/2013-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/diverse-specificity-and-effector-function-among-human-antibodies-to-hiv-1-envelope-glycoprotein-epitopes-exposed-by-cd4-binding/2013-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/dysregulated-tim-3-expression-on-natural-killer-cells-is-associated-with-increased-galectin-9-levels-in-hiv-1-infection/2013-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/first-in-human-evaluation-of-the-safety-and-immunogenicity-of-a-recombinant-adenovirus-serotype-26-hiv-1-env-vaccine-ipcavd-001/2013-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/functional-perturbation-of-classical-natural-killer-and-innate-lymphoid-cells-in-the-oral-mucosa-during-siv-infection/2013-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/gagpol-specific-cd4-t-cells-increase-the-antibody-response-to-env-by-intrastructural-help/2013-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/generation-of-effector-memory-t-cell-based-mucosal-and-systemic-immunity-with-pulmonary-nanoparticle-vaccination/2013-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/generation-of-lineage-related-mucosally-transmissible-subtype-c-r5-simian-human-immunodeficiency-viruses-capable-of-aids-development-induction-of-neurological-disease-and-coreceptor-switching-in-rh/2013-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/hepatitis-c-genotype-1-mosaic-vaccines-are-immunogenic-in-mice-and-induce-higher-t-cell-responses-than-natural-strains/2013-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/hiv-1-suppression-and-durable-control-by-combining-single-broadly-neutralizing-antibodies-and-antiretroviral-drugs-in-humanized-mice/2013-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/identification-of-broadly-neutralizing-antibody-epitopes-in-the-hiv-1-envelope-glycoprotein-using-evolutionary-models/2013-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/immune-focusing-and-enhanced-neutralization-induced-by-hiv-1-gp140-chemical-cross-linking/2013-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/location-and-dynamics-of-the-immunodominant-cd8-t-cell-response-to-sivdnef-immunization-and-sivmac251-vaginal-challenge/2013-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/loss-of-bone-marrow-nk-cells-during-siv-infection-is-associated-with-increased-turnover-rates-and-cytotoxicity-but-not-changes-in-trafficking/2013-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/monkeypox-virus-infection-of-rhesus-macaques-induces-massive-expansion-of-natural-killer-cells-but-suppresses-natural-killer-cell-functions/2013-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/multi-functional-plasmacytoid-dendritic-cells-redistribute-to-gut-tissues-during-simian-immunodeficiency-virus-infection/2013-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/multimodal-mechanism-of-action-of-allosteric-hiv-1-integrase-inhibitors/2020-03-23T09:30:59-04:00https://cvvr.hms.harvard.edu/publication/no-monkey-business-why-studying-nk-cells-in-non-human-primates-pays-off/2013-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/novel-hiv-vaccine-strategies-overview-and-perspective/2013-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/nucleoporin-nup153-phenylalanine-glycine-motifs-engage-a-common-binding-pocket-within-the-hiv-1-capsid-protein-to-mediate-lentiviral-infectivity/2020-03-23T09:30:59-04:00https://cvvr.hms.harvard.edu/publication/polymer-multilayer-tattooing-for-enhanced-dna-vaccination/2013-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/polymorphic-ledgf-p75-variants-support-efficient-hiv-1-infection-ex-vivo/2020-03-23T09:30:59-04:00https://cvvr.hms.harvard.edu/publication/protective-efficacy-of-a-global-hiv-1-mosaic-vaccine-against-acquisition-of-heterologous-shiv-challenges-in-rhesus-monkeys/2013-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/restricting-hiv-1-pathways-for-escape-using-rationally-designed-anti-hiv-1-antibodies/2013-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/safety-and-immongenicity-of-modified-vaccinia-ankara-in-hematopoietic-stem-cell-transplant-recipients-a-randomized-controlled-trial/2013-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/somatic-mutations-of-the-immunoglobulin-framework-are-generally-required-for-broad-and-potent-hiv-1-neutralization/2013-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/strategic-addition-of-an-n-linked-glycan-to-a-monoclonal-antibody-improves-its-hiv-1-neutralizing-activity/2013-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/the-a128t-resistance-mutation-reveals-aberrant-protein-multimerization-as-the-primary-mechanism-of-action-of-allosteric-hiv-1-integrase-inhibitors/2020-03-23T09:30:59-04:00https://cvvr.hms.harvard.edu/publication/the-effects-of-somatic-hypermutation-on-neutralizing-and-binding-in-the-pgt121-family-of-broadly-neutralizing-antibodies/2013-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/the-production-characterization-and-application-of-monoclonal-antibodies-generated-by-immunization-with-hiv-1c-clade-rgp140-envelope-protein/2013-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/the-quadrivalent-approach-to-influenza-vaccination/2013-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/therapeutic-efficacy-of-potent-neutralizing-hiv-1-specific-monoclonal-antibodies-in-shiv-infected-rhesus-monkeys/2020-03-18T14:52:29-04:00https://cvvr.hms.harvard.edu/publication/vaccine-delivery-with-microneedle-skin-patches-in-nonhuman-primates/2013-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/vaccine-induction-of-antibodies-against-a-structurally-heterogeneous-site-of-immune-pressure-within-hiv-1-envelope-protein-variable-regions-1-and-2/2013-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/viral-and-cellular-requirements-for-the-nuclear-entry-of-retroviral-preintegration-nucleoprotein-complexes/2020-03-23T09:30:59-04:00https://cvvr.hms.harvard.edu/publication/a-mouse-model-for-hiv-1-entry/2012-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/accelerated-heterologous-adenovirus-prime-boost-siv-vaccine-in-neonatal-rhesus-monkeys/2012-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/ad5-specific-neutralizing-antibodies-target-multiple-hexon-hypervariable-regions/2012-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/ad5ad48-hexon-hypervariable-region-substitutions-lead-to-toxicity-and-increased-inflammatory-responses-following-intravenous-delivery/2012-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/adcc-develops-over-time-during-persistent-infection-with-live-attenuated-siv-and-is-associated-with-complete-protection-against-sivmac251-challenge/2012-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/adenovirus-serotype-26-utilizes-cd46-as-a-primary-cellular-receptor-and-only-transiently-activates-t-lymphocytes-following-vaccination-of-rhesus-monkeys/2012-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/adenovirus-serotype-5-neutralizing-antibodies-target-both-hexon-and-fiber-following-vaccination-and-natural-infection/2012-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/anti-cd4-monoclonal-antibody-ibalizumab-exhibits-breadth-and-potency-against-hiv-1-with-natural-resistance-mediated-by-the-loss-of-a-v5-glycan-in-envelope/2012-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/breadth-of-cellular-and-humoral-immune-responses-elicited-in-rhesus-monkeys-by-multi-valent-mosaic-and-consensus-immunogens/2012-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/broad-neutralization-by-a-combination-of-antibodies-recognizing-the-cd4-binding-site-and-a-new-conformational-epitope-on-the-hiv-1-envelope-protein/2012-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/complex-type-n-glycan-recognition-by-potent-broadly-neutralizing-hiv-antibodies/2012-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/correlation-of-recombinant-integrase-activity-and-functional-preintegration-complex-formation-during-acute-infection-by-replication-defective-integrase-mutant-human-immunodeficiency-virus/2020-03-23T09:30:59-04:00https://cvvr.hms.harvard.edu/publication/different-pattern-of-immunoglobulin-gene-usage-by-hiv-1-compared-to-non-hiv-1-antibodies-derived-from-the-same-infected-subject/2012-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/differential-effects-of-human-immunodeficiency-virus-type-1-capsid-and-cellular-factors-nucleoporin-153-and-ledgf-p75-on-the-efficiency-and-specificity-of-viral-dna-integration/2020-03-23T09:30:59-04:00https://cvvr.hms.harvard.edu/publication/engineering-expression-purification-and-characterization-of-stable-clade-a-b-recombinant-soluble-heterotrimeric-gp140-proteins/2012-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/enhanced-hiv-1-neutralization-by-antibody-heteroligation/2012-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/envelope-variable-region-4-is-the-first-target-of-neutralizing-antibodies-in-early-simian-immunodeficiency-virus-mac251-infection-of-rhesus-monkeys/2012-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/evolution-of-an-hiv-glycan-dependent-broadly-neutralizing-antibody-epitope-through-immune-escape/2012-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/focus-and-breadth-of-cellular-immune-responses-elicited-by-a-heterologous-insert-prime-boost-vaccine-regimen-in-rhesus-monkeys/2012-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/full-length-hiv-1-immunogens-induce-greater-magnitude-and-comparable-breadth-of-t-lymphocyte-responses-to-conserved-hiv-1-regions-compared-with-conserved-region-only-hiv-1-immunogens-in-rhesus-monkeys/2012-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/functional-and-immunochemical-cross-reactivity-of-v2-specific-monoclonal-antibodies-from-hiv-1-infected-individuals/2012-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/gag-specific-cellular-immunity-determines-in-vitro-viral-inhibition-and-in-vivo-virologic-control-following-simian-immunodeficiency-virus-challenges-of-vaccinated-rhesus-monkeys/2012-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/hiv-therapy-by-a-combination-of-broadly-neutralizing-antibodies-in-humanized-mice/2012-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/hiv-1-envelope-trimer-elicits-more-potent-neutralizing-antibody-responses-than-monomeric-gp120/2012-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/hiv-1-neutralization-coverage-is-improved-by-combining-monoclonal-antibodies-that-target-independent-epitopes/2012-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/hrp2-determines-the-efficiency-and-specificity-of-hiv-1-integration-in-ledgf-p75-knockout-cells-but-does-not-contribute-to-the-antiviral-activity-of-a-potent-ledgf-p75-binding-site-integrase-inhibitor/2020-03-23T09:30:59-04:00https://cvvr.hms.harvard.edu/publication/human-immunodeficiency-virus-type-1-hiv-1-capsid-mutation-n74d-alters-cyclophilin-a-dependence-and-impairs-macrophage-infection/2020-03-23T09:30:59-04:00https://cvvr.hms.harvard.edu/publication/impact-of-anti-orthopoxvirus-neutralizing-antibodies-induced-by-a-heterologous-prime-boost-hiv-1-vaccine-on-insert-specific-immune-responses/2012-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/in-vivo-anti-hiv-activity-of-the-heparin-activated-serine-protease-inhibitor-antithrombin-iii-encapsulated-in-lymph-targeting-immunoliposomes/2012-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/increased-program-cell-death-1-expression-on-t-lymphocytes-of-patients-with-progressive-multifocal-leukoencephalopathy/2012-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/macaque-studies-of-vaccine-and-microbicide-combinations-for-preventing-hiv-1-sexual-transmission/2012-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/mixed-adjuvant-formulations-reveal-a-new-combination-that-elicits-antibody-response-comparable-to-freunds-adjuvants/2012-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/multimode-cooperative-mechanism-of-action-of-allosteric-hiv-1-integrase-inhibitors/2020-03-23T09:30:59-04:00https://cvvr.hms.harvard.edu/publication/pathogenic-simian-immunodeficiency-virus-infection-is-associated-with-expansion-of-the-enteric-virome/2012-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/pgv04-an-hiv-1-gp120-cd4-binding-site-antibody-is-broad-and-potent-in-neutralization-but-does-not-induce-conformational-changes-characteristic-of-cd4/2012-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/potent-and-broad-neutralization-of-hiv-1-by-a-llama-antibody-elicited-by-immunization/2012-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/preexisting-adenovirus-seropositivity-is-not-associated-with-increased-hiv-1-acquisition-in-three-hiv-1-vaccine-efficacy-trials/2012-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/priming-t-cell-responses-with-recombinant-measles-vaccine-vector-in-a-heterologous-prime-boost-setting-in-non-human-primates/2012-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/retroviral-integrase-proteins-and-hiv-1-dna-integration/2020-03-23T09:30:59-04:00https://cvvr.hms.harvard.edu/publication/signature-biochemical-properties-of-broadly-cross-reactive-hiv-1-neutralizing-antibodies-in-human-plasma/2012-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/siv-infection-induces-accumulation-of-plasmacytoid-dendritic-cells-to-the-gut-mucosa/2012-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/the-host-proteins-transportin-sr2-tnpo3-and-cyclophilin-a-exert-opposing-effects-on-hiv-1-uncoating/2020-03-23T09:30:59-04:00https://cvvr.hms.harvard.edu/publication/the-number-of-tlr9-agonist-motifs-in-the-adenovirus-genome-correlates-with-induction-of-dc-maturation-by-adenovirus-immune-complexes/2012-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/the-road-to-an-effective-hiv-vaccine/2012-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/the-structural-biology-of-hiv-1-mechanistic-and-therapeutic-insights/2020-03-23T09:30:59-04:00https://cvvr.hms.harvard.edu/publication/vaccination-with-adenovirus-serotypes-35-26-and-48-elicits-greater-innate-cytokine-responses-than-adenovirus-serotype-5-in-rhesus-monkeys/2012-05-01T00:00:00-04:00https://cvvr.hms.harvard.edu/publication/vaccine-protection-against-acquisition-of-neutralization-resistant-siv-challenges-in-rhesus-monkeys/2020-04-23T11:56:50-04:00https://cvvr.hms.harvard.edu/publication/optimization-and-qualification-of-a-functional-anti-drug-antibody-assay-for-hiv-1-bnabs/2020-03-11T15:00:41-04:00https://cvvr.hms.harvard.edu/publication/framework-mutations-of-the-10-1074-bnab-increase-conformational-stability-manufacturability-and-stability-while-preserving-full-neutralization-activity-2/2020-01-23T15:17:42-05:00https://cvvr.hms.harvard.edu/publication/a-peptide-derived-from-lens-epithelium-derived-growth-factor-stimulates-hiv-1-dna-integration-and-facilitates-intasome-structural-studies/2020-03-23T09:30:58-04:00https://cvvr.hms.harvard.edu/publication/structural-basis-of-second-generation-inhibitor-action-and-viral-resistance/2020-03-23T09:30:58-04:00https://cvvr.hms.harvard.edu/publication/antibody-and-tlr7-agonist-delay-viral-rebound-in-shiv-infected-monkeys-2/2020-03-18T11:19:16-04:00https://cvvr.hms.harvard.edu/publication/functional-perturbation-of-mucosal-group-3-innate-lymphoid-and-natural-killer-cells-in-simian-human-immunodeficiency-virus-simian-immunodeficiency-virus-infected-infant-rhesus-macaques/2020-04-30T11:38:47-04:00https://cvvr.hms.harvard.edu/publication/delineation-and-modulation-of-the-natural-killer-cell-transcriptome-in-rhesus-macaques-during-zikv-and-siv-infections/2020-04-30T11:41:45-04:00https://cvvr.hms.harvard.edu/publication/functional-perturbation-of-mucosal-group-3-innate-lymphoid-and-natural-killer-cells-in-simian-human-immunodeficiency-virus-simian-immunodeficiency-virus-infected-infant-rhesus-macaques-2/2020-05-11T11:56:23-04:00https://cvvr.hms.harvard.edu/publication/characterization-of-circulating-natural-killer-cells-in-neotropical-primates-2/2020-05-11T11:58:15-04:00https://cvvr.hms.harvard.edu/publication/all-trans-retinoic-acid-imprints-expression-of-the-gut-homing-marker-%ce%b14%ce%b27-while-suppressing-lymph-node-homing-of-dendritic-cells-clinical-and-vaccine-immunology/2020-05-11T11:59:32-04:00https://cvvr.hms.harvard.edu/publication/no-monkey-business-why-studying-nk-cells-in-non-human-primates-pays-off-frontiers-in-immunology/2020-05-11T13:29:30-04:00https://cvvr.hms.harvard.edu/publication/differential-outcomes-following-optimization-of-simian-human-immunodeficiency-viruses-from-clades-ae-b-and-c/2020-05-19T13:12:46-04:00https://cvvr.hms.harvard.edu/publication/evolution-of-the-innate-and-adaptive-immune-response-in-women-with-acute-zika-virus-infection/2020-05-19T13:46:51-04:00https://cvvr.hms.harvard.edu/publication/vaccines-and-broadly-neutralizing-antibodies-for-hiv-1-prevention/2020-05-19T13:17:32-04:00https://cvvr.hms.harvard.edu/publication/potent-zika-and-dengue-cross-neutralizing-antibodies-induced-by-zika-vaccination-in-a-dengue-experienced-donor/2020-05-19T13:45:34-04:00https://cvvr.hms.harvard.edu/publication/comparison-of-shortened-mosaic-hiv-1-vaccine-schedules-a-randomised-double-blind-placebo-controlled-phase-1-trial-ipcavd010-hpx1002-and-a-preclinical-study-in-rhesus-monkeys-nhp-17-22/2020-05-19T13:46:24-04:00https://cvvr.hms.harvard.edu/publication/dna-vaccine-protection-against-sars-cov-2-in-rhesus-macaques/2020-08-30T14:13:03-04:00https://cvvr.hms.harvard.edu/publication/sars-cov-2-infection-protects-against-rechallenge-in-rhesus-macaques/2020-08-30T14:13:24-04:00https://cvvr.hms.harvard.edu/publication/single-shot-ad26-vaccine-protects-against-sars-cov-2-in-rhesus-macaques/2020-08-30T14:17:33-04:00https://cvvr.hms.harvard.edu/publication/ad26-vaccine-protects-against-sars-cov-2-severe-clinical-disease-in-hamsters/2020-09-03T10:10:15-04:00https://cvvr.hms.harvard.edu/publication/animal-models-for-covid-19/2020-10-08T10:27:15-04:00https://cvvr.hms.harvard.edu/publication/approaches-and-challenges-in-sars-cov-2-vaccine-development/2020-10-08T10:30:15-04:00https://cvvr.hms.harvard.edu/publication/virus-receptor-interactions-of-glycosylated-sars-cov-2-spike-and-human-ace2-receptor/2020-10-08T10:29:54-04:00https://cvvr.hms.harvard.edu/publication/distinct-early-serological-signatures-track-with-sars-cov-2-survival/2020-10-08T10:32:16-04:00https://cvvr.hms.harvard.edu/publication/vascular-disease-and-thrombosis-in-sars-cov-2-infected-rhesus-macaques/2020-11-02T09:10:40-05:00https://cvvr.hms.harvard.edu/publication/correlates-of-protection-against-sars-cov-2-in-rhesus-macaques/2020-12-05T16:27:57-05:00https://cvvr.hms.harvard.edu/publication/interim-results-of-a-phase-1-2a-trial-of-ad26-cov2-s-covid-19-vaccine/2021-01-15T14:14:50-05:00https://cvvr.hms.harvard.edu/publication/persistence-of-viral-rna-in-lymph-nodes-in-art-suppressed-siv-shiv-infected-rhesus-macaques/2021-03-11T14:11:24-05:00https://cvvr.hms.harvard.edu/publication/coronavirus-specific-antibody-cross-reactivity-in-rhesus-macaques-following-sars-cov-2-vaccination-and-infection/2021-03-11T14:09:38-05:00https://cvvr.hms.harvard.edu/publication/triggered-could-refocused-cell-signaling-be-key-to-natural-killer-cell-based-hiv-immunotherapeutics/2021-04-03T14:35:25-04:00https://cvvr.hms.harvard.edu/publication/a-trimeric-human-angiotensin-converting-enzyme-2-as-an-anti-sars-cov-2-agent/2021-04-03T14:52:54-04:00https://cvvr.hms.harvard.edu/publication/building-trust-in-covid-19-vaccines-and-beyond-through-authentic-community-investment/2021-04-03T14:45:50-04:00https://cvvr.hms.harvard.edu/publication/a-double-blind-randomized-placebo-controlled-phase-1-study-of-ad26-zikv-001-an-ad26-vectored-anti-zika-virus-vaccine/2021-04-03T14:51:48-04:00https://cvvr.hms.harvard.edu/publication/immunogenicity-of-the-ad26-cov2-s-vaccine-for-covid-19/2021-04-04T21:04:12-04:00https://cvvr.hms.harvard.edu/publication/immunogenicity-of-covid-19-mrna-vaccines-in-pregnant-and-lactating-women/2021-05-14T13:51:50-04:00https://cvvr.hms.harvard.edu/publication/friends-or-foes-the-knowns-and-unknowns-of-natural-killer-cell-biology-in-covid-19-and-other-coronaviruses-in-july-2020/2021-05-20T10:34:40-04:00https://cvvr.hms.harvard.edu/publication/skipped-over-tuning-natural-killer-cells-toward-hiv-through-alternative-splicing/2021-05-20T10:38:00-04:00https://cvvr.hms.harvard.edu/publication/characterization-of-rhesus-macaque-liver-resident-cd49a-nk-cells-during-retrovirus-infections/2021-05-20T10:45:11-04:00https://cvvr.hms.harvard.edu/publication/safety-and-efficacy-of-single-dose-ad26-cov2-s-vaccine-against-covid-19/2021-06-12T15:05:11-04:00https://cvvr.hms.harvard.edu/publication/low-dose-ad26-cov2-s-protection-against-sars-cov-2-challenge-in-rhesus-macaques/2021-06-21T10:38:29-04:00https://cvvr.hms.harvard.edu/publication/protective-efficacy-of-ad26-cov2-s-against-sars-cov-2-b-1-351-in-macaques/2021-06-25T11:14:25-04:00https://cvvr.hms.harvard.edu/publication/correlates-of-neutralization-against-sars-cov-2-variants-of-concern-by-early-pandemic-sera/2021-07-02T16:27:12-04:00https://cvvr.hms.harvard.edu/publication/probiotic-supplementation-reduces-inflammatory-profiles-but-does-not-prevent-oral-immune-perturbations-during-siv-infection/2021-07-20T09:02:58-04:00https://cvvr.hms.harvard.edu/publication/immunogenicity-safety-and-efficacy-of-sequential-immunizations-with-an-siv-based-idlv-expressing-ch505-envs/2021-08-03T14:34:43-04:00https://cvvr.hms.harvard.edu/publication/lipid-nanoparticle-encapsulated-nucleoside-modified-mrna-vaccines-elicit-polyfunctional-hiv-1-antibodies-comparable-to-proteins-in-nonhuman-primates/2021-08-03T14:37:19-04:00https://cvvr.hms.harvard.edu/publication/recombinant-mva-prime-elicits-neutralizing-antibody-responses-by-inducing-antigen-specific-b-cells-in-the-germinal-center/2021-08-03T14:39:57-04:00https://cvvr.hms.harvard.edu/publication/d614g-spike-mutation-increases-sars-cov-2-susceptibility-to-neutralization/2021-08-03T14:43:52-04:00https://cvvr.hms.harvard.edu/publication/fab-dimerized-glycan-reactive-antibodies-are-a-structural-category-of-natural-antibodies/2021-08-03T14:46:04-04:00https://cvvr.hms.harvard.edu/publication/immunogenicity-of-ad26-cov2-s-vaccine-against-sars-cov-2-variants-in-humans-2/2021-08-27T14:47:34-04:00https://cvvr.hms.harvard.edu/publication/deletion-of-the-sars-cov-2-spike-cytoplasmic-tail-increases-infectivity-in-pseudovirus-neutralization-assays/2021-08-27T14:53:14-04:00https://cvvr.hms.harvard.edu/publication/comparison-of-subgenomic-and-total-rna-in-sars-cov-2-challenged-rhesus-macaques/2021-08-27T14:54:44-04:00https://cvvr.hms.harvard.edu/publication/durable-humoral-and-cellular-immune-responses-8-months-after-ad26-cov2-s-vaccination/2021-08-27T15:02:08-04:00https://cvvr.hms.harvard.edu/publication/subcutaneous-regen-cov-antibody-combination-to-prevent-covid-19/2021-08-27T15:03:23-04:00https://cvvr.hms.harvard.edu/publication/differential-kinetics-of-immune-responses-elicited-by-covid-19-vaccines/2021-11-21T11:02:45-05:00https://cvvr.hms.harvard.edu/publication/immunogenicity-of-covid-19-mrna-vaccines-in-pregnant-and-lactating-women-2/2021-11-21T11:08:18-05:00https://cvvr.hms.harvard.edu/publication/review-of-the-immune-mechanisms-of-preeclampsia-and-the-potential-of-immune-modulating-therapy/2021-11-21T11:10:32-05:00https://cvvr.hms.harvard.edu/publication/assessment-of-maternal-and-neonatal-sars-cov-2-viral-load-transplacental-antibody-transfer-and-placental-pathology-in-pregnancies-during-the-covid-19-pandemic/2021-11-21T11:15:49-05:00https://cvvr.hms.harvard.edu/publication/compassionate-use-of-remdesivir-in-pregnant-women-with-severe-covid-19/2021-11-21T11:19:15-05:00https://cvvr.hms.harvard.edu/publication/sustained-maternal-antibody-and-cellular-immune-responses-in-pregnant-women-infected-with-zika-virus-and-mother-to-infant-transfer-of-zika-specific-antibodies/2021-11-21T11:22:27-05:00https://cvvr.hms.harvard.edu/publication/placental-sflt1-is-associated-with-complement-activation-and-syncytiotrophoblast-damage-in-preeclampsia/2021-11-21T11:25:44-05:00https://cvvr.hms.harvard.edu/publication/self-encounters-of-the-third-kind-lymph-node-stroma-promotes-tolerance-to-peripheral-tissue-antigens/2021-11-21T12:06:05-05:00https://cvvr.hms.harvard.edu/publication/optimization-of-non-coding-regions-for-a-non-modified-mrna-covid-19-vaccine/2022-04-19T11:22:55-04:00https://cvvr.hms.harvard.edu/publication/vaccines-elicit-highly-conserved-cellular-immunity-to-sars-cov-2-omicron/2022-02-15T08:56:50-05:00https://cvvr.hms.harvard.edu/publication/clinical-development-and-approval-of-covid-19-vaccines/2022-02-15T09:14:48-05:00https://cvvr.hms.harvard.edu/publication/covid-19-vaccines-adenoviral-vectors/2022-04-19T11:24:53-04:00https://cvvr.hms.harvard.edu/publication/long-acting-capsid-inhibitor-protects-macaques-from-repeat-shiv-challenges/2022-02-15T09:19:20-05:00https://cvvr.hms.harvard.edu/publication/final-analysis-of-efficacy-and-safety-of-single-dose-ad26-cov2-s/2022-02-15T09:20:22-05:00https://cvvr.hms.harvard.edu/publication/passive-transfer-of-ad26-cov2-s-elicited-igg-from-humans-attenuates-sars-cov-2-disease-in-hamsters/2022-02-15T09:21:58-05:00https://cvvr.hms.harvard.edu/publication/protective-efficacy-of-gastrointestinal-sars-cov-2-delivery-against-intranasal-and-intratracheal-sars-cov-2-challenge-in-rhesus-macaques/2022-02-15T09:24:05-05:00https://cvvr.hms.harvard.edu/publication/a-combination-of-two-human-neutralizing-antibodies-prevents-sars-cov-2-infection-in-cynomolgus-macaques/2022-02-15T09:26:58-05:00https://cvvr.hms.harvard.edu/publication/spatial-and-genomic-correlates-of-hiv-1-integration-site-targeting/2022-04-19T11:15:43-04:00https://cvvr.hms.harvard.edu/publication/rigrag-high-resolution-mapping-of-genic-targeting-preferences-during-hiv-1-integration-in-vitro-and-in-vivo/2022-04-19T11:16:09-04:00https://cvvr.hms.harvard.edu/publication/publisher-correction-hiv-1-replication-complexes-accumulate-in-nuclear-speckles-and-integrate-into-speckle-associated-genomic-domains/2022-04-19T11:16:30-04:00https://cvvr.hms.harvard.edu/publication/structural-and-mechanistic-bases-for-a-potent-hiv-1-capsid-inhibitor/2022-04-19T11:16:56-04:00https://cvvr.hms.harvard.edu/publication/cpsf6-dependent-targeting-of-speckle-associated-domains-distinguishes-primate-from-nonprimate-lentiviral-integration/2022-04-19T11:17:18-04:00https://cvvr.hms.harvard.edu/publication/hiv-1-replication-complexes-accumulate-in-nuclear-speckles-and-integrate-into-speckle-associated-genomic-domains/2022-04-19T11:17:58-04:00https://cvvr.hms.harvard.edu/publication/differential-role-for-phosphorylation-in-alternative-polyadenylation-function-versus-nuclear-import-of-sr-like-protein-cpsf6-2/2022-04-19T11:18:43-04:00https://cvvr.hms.harvard.edu/publication/comparable-neutralization-of-the-sars-cov-2-omicron-ba-1-and-ba-2-variants/2022-04-19T11:27:22-04:00https://cvvr.hms.harvard.edu/publication/defining-the-risk-of-sars-cov-2-variants-on-immune-protection/2022-04-19T11:24:03-04:00https://cvvr.hms.harvard.edu/publication/hiv-envelope-antibodies-and-tlr7-agonist-partially-prevent-viral-rebound-in-chronically-shiv-infected-monkeys/2022-04-26T08:49:07-04:00https://cvvr.hms.harvard.edu/publication/vaccine-protection-against-the-sars-cov-2-omicron-variant-in-macaques/2022-04-26T09:37:13-04:00https://cvvr.hms.harvard.edu/publication/mrna-1273-and-bnt162b2-covid-19-vaccines-elicit-antibodies-with-differences-in-fc-mediated-effector-functions/2022-04-26T10:42:04-04:00https://cvvr.hms.harvard.edu/publication/sars-cov-2-receptor-binding-domain-displayed-on-hbsag-virus-like-particles-elicits-protective-immunity-in-macaques/2022-04-26T10:44:56-04:00https://cvvr.hms.harvard.edu/publication/characterization-of-immune-responses-in-fully-vaccinated-individuals-after-breakthrough-infection-with-the-sars-cov-2-delta-variant/2022-04-26T10:46:56-04:00https://cvvr.hms.harvard.edu/publication/neutralization-escape-by-sars-cov-2-omicron-subvariants-ba-2-12-1-ba-4-and-ba-5/2022-07-06T11:25:30-04:00https://cvvr.hms.harvard.edu/publication/durability-of-heterologous-and-homologous-covid-19-vaccine-boost-regimens/2022-07-06T11:28:24-04:00https://cvvr.hms.harvard.edu/publication/high-dose-inhaled-nitric-oxide-for-the-treatment-of-spontaneously-breathing-pregnant-patients-with-severe-coronavirus-disease-2019-pneumonia/2022-07-06T11:33:39-04:00https://cvvr.hms.harvard.edu/publication/cd8-t-cells-contribute-to-vaccine-protection-against-sars-cov-2-in-macaques/2022-08-09T15:32:29-04:00https://cvvr.hms.harvard.edu/publication/allosteric-integrase-inhibitor-influences-on-hiv-1-integration-and-roles-of-ledgf-p75-and-hdgfl2-host-factors/2022-09-12T09:30:45-04:00https://cvvr.hms.harvard.edu/publication/neutralization-escape-by-sars-cov-2-omicron-subvariant-ba-4-6/2023-01-24T14:47:55-05:00https://cvvr.hms.harvard.edu/publication/9219/2023-01-12T09:49:39-05:00https://cvvr.hms.harvard.edu/publication/substantial-neutralization-escape-by-sars-cov-2-omicron-variants-bq-1-1-and-xbb-1/2023-01-24T14:38:00-05:00https://cvvr.hms.harvard.edu/publication/a-genetically-engineered-stem-cell-derived-cellular-vaccine/2023-01-24T14:41:28-05:00https://cvvr.hms.harvard.edu/publication/protection-against-sars-cov-2-omicron-ba-1-variant-challenge-in-macaques-by-prime-boost-vaccination-with-ad26-cov2-s-and-spfn/2023-01-24T14:43:11-05:00https://cvvr.hms.harvard.edu/publication/safety-and-immunogenicity-of-ad26-vectored-hiv-vaccine-with-mosaic-immunogens-and-a-novel-mosaic-envelope-protein-in-hiv-uninfected-adults-a-phase-1-2a-study/2023-01-24T14:45:23-05:00https://cvvr.hms.harvard.edu/publication/immunogenicity-and-protective-efficacy-of-a-rhesus-adenoviral-vaccine-targeting-conserved-covid-19-replication-transcription-complex/2023-01-24T14:46:52-05:00https://cvvr.hms.harvard.edu/publication/covid-19-vaccines-immunity-variants-boosters/2023-01-24T14:49:19-05:00https://cvvr.hms.harvard.edu/publication/immunogenicity-and-protective-efficacy-of-gbp510-as03-vaccine-against-sars-cov-2-delta-challenge-in-rhesus-macaques/2023-02-23T10:49:41-05:00https://cvvr.hms.harvard.edu/publication/booster-with-ad26-cov2-s-or-omicron-adapted-vaccine-enhanced-immunity-and-efficacy-against-sars-cov-2-omicron-in-macaques/2024-01-24T12:31:04-05:00https://cvvr.hms.harvard.edu/publication/maps-pathologist-level-cell-type-annotation-from-tissue-images-through-machine-learning/2024-01-18T10:31:16-05:00https://cvvr.hms.harvard.edu/publication/mrna-vaccines-against-sars-cov-2-induce-divergent-antigen-specific-t-cell-responses-in-patients-with-lung-cancer/2024-01-18T10:50:26-05:00https://cvvr.hms.harvard.edu/publication/broadly-neutralizing-antibody-mediated-protection-against-simian-hiv-infection-among-macaques-with-vaginal-sexually-transmitted-infections/2024-01-24T10:26:34-05:00https://cvvr.hms.harvard.edu/publication/safety-and-immunogenicity-of-ad26-vectored-hiv-vaccine-with-mosaic-immunogens-and-a-novel-mosaic-envelope-protein-in-hiv-uninfected-adults-a-phase-1-2a-study-2/2024-01-24T10:34:32-05:00https://cvvr.hms.harvard.edu/publication/a-microneedle-vaccine-printer-for-thermostable-covid-19-mrna-vaccines/2024-01-24T10:45:15-05:00https://cvvr.hms.harvard.edu/publication/attenuated-mycobacterium-tuberculosis-vaccine-protection-in-a-low-dose-murine-challenge-model/2024-01-24T11:48:21-05:00https://cvvr.hms.harvard.edu/publication/divide-and-conquer-broadly-neutralizing-antibody-combinations-for-improved-hiv-1-viral-coverage/2024-01-24T10:52:04-05:00https://cvvr.hms.harvard.edu/publication/peripheral-blood-biomarkers-predict-viral-rebound-following-antiretroviral-therapy-discontinuation-in-siv-infected-early-art-treated-rhesus-macaques/2024-01-24T10:59:52-05:00https://cvvr.hms.harvard.edu/publication/delayed-and-attenuated-antibody-responses-to-coronavirus-disease-2019-vaccination-with-poor-cross-variant-neutralization-in-solid-organ-transplant-recipients-a-prospective-longitudinal-study/2024-01-24T11:47:31-05:00https://cvvr.hms.harvard.edu/publication/activation-of-coagulation-and-proinflammatory-pathways-in-thrombosis-with-thrombocytopenia-syndrome-and-following-covid-19-vaccination/2024-01-24T11:09:23-05:00https://cvvr.hms.harvard.edu/publication/circularized-nanodiscs-for-multivalent-mosaic-display-of-sars-cov-2-spike-protein-antigens/2024-01-24T11:53:20-05:00https://cvvr.hms.harvard.edu/publication/efficacy-of-messenger-rna-1273-against-severe-acute-respiratory-syndrome-coronavirus-2-acquisition-in-young-adults-from-march-to-december-2021/2024-01-24T12:06:44-05:00https://cvvr.hms.harvard.edu/publication/sars-cov-2-hybrid-immunity-the-best-of-both-worlds/2024-01-24T12:02:16-05:00https://cvvr.hms.harvard.edu/publication/sars-cov-2-viral-persistence-in-lung-alveolar-macrophages-is-controlled-by-ifn-%ce%b3-and-nk-cells/2024-01-24T12:05:16-05:00https://cvvr.hms.harvard.edu/publication/antigen-specific-memory-nk-cell-responses-against-hiv-and-influenza-use-the-nkg2-hla-e-axis/2024-01-24T12:09:15-05:00https://cvvr.hms.harvard.edu/publication/carbohydrate-fatty-acid-monosulphate-oil-in-water-adjuvant-enhances-sars-cov-2-rbd-nanoparticle-induced-immunogenicity-and-protection-in-mice/2024-01-24T12:19:58-05:00https://cvvr.hms.harvard.edu/publication/publisher-correction-carbohydrate-fatty-acid-monosulphate-oil-in-water-adjuvant-enhances-sars-cov-2-rbd-nanoparticle-induced-immunogenicity-and-protection-in-mice/2024-01-24T12:28:30-05:00https://cvvr.hms.harvard.edu/publication/antiretroviral-therapy-reveals-triphasic-decay-of-intact-siv-genomes-and-persistence-of-ancestral-variants/2024-01-24T12:34:08-05:00https://cvvr.hms.harvard.edu/publication/ad26-cov2-s-and-sars-cov-2-spike-protein-ferritin-nanoparticle-vaccine-protect-against-sars-cov-2-omicron-ba-5-challenge-in-macaques/2024-01-24T12:37:55-05:00https://cvvr.hms.harvard.edu/publication/isolation-of-a-rhesus-calicivirus-that-can-replicate-in-human-cells/2024-01-24T12:41:18-05:00https://cvvr.hms.harvard.edu/publication/selective-sars-cov2-ba-2-escape-of-antibody-fc-fc-receptor-interactions/2024-01-24T12:44:10-05:00https://cvvr.hms.harvard.edu/publication/progress-in-vaccine-development-for-infectious-diseases-a-keystone-symposia-report/2024-01-24T12:51:32-05:00https://cvvr.hms.harvard.edu/publication/zika-specific-neutralizing-antibodies-targeting-inter-dimer-envelope-epitopes/2024-01-24T12:53:57-05:00https://cvvr.hms.harvard.edu/publication/altered-cytokine-production-in-human-intervillous-blood-t-cells-in-preeclampsia/2024-01-24T12:56:41-05:00https://cvvr.hms.harvard.edu/publication/safety-tolerability-pharmacokinetics-and-immunological-activity-of-dual-combinations-and-triple-combinations-of-anti-hiv-monoclonal-antibodies-pgt121-pgdm1400-10-1074-and-vrc07-523ls-administere/2024-01-24T12:59:42-05:00https://cvvr.hms.harvard.edu/publication/mpox-infection-protects-against-re-challenge-in-rhesus-macaques/2024-01-24T13:03:01-05:00https://cvvr.hms.harvard.edu/publication/biphasic-decay-of-intact-shiv-genomes-following-initiation-of-antiretroviral-therapy-complicates-analysis-of-interventions-targeting-the-reservoir/2024-01-24T14:32:24-05:00https://cvvr.hms.harvard.edu/publication/mosaic-hiv-1-vaccination-induces-anti-viral-cd8-t-cell-functionality-in-the-phase-1-2a-clinical-trial-approach/2024-01-24T14:38:43-05:00https://cvvr.hms.harvard.edu/publication/neutralization-escape-by-sars-cov-2-omicron-subvariant-ba-2-86/2024-01-24T14:43:48-05:00https://cvvr.hms.harvard.edu/publication/early-emerging-sars-cov-2-spike-mutants-are-diversified-in-virologic-properties-but-elicit-compromised-antibody-responses/2024-01-24T14:53:41-05:00https://cvvr.hms.harvard.edu/publication/mucosal-boosting-enhances-vaccine-protection-against-sars-cov-2-in-macaques/2024-01-24T14:56:05-05:00https://cvvr.hms.harvard.edu/publication/prophylactic-hiv-1-vaccine-trials-past-present-and-future/2024-01-24T14:58:00-05:00https://cvvr.hms.harvard.edu/publication/covid-19-therapeutics-and-considerations-for-pregnancy/2024-01-24T15:46:51-05:00https://cvvr.hms.harvard.edu/publication/resilience-as-a-potential-modifier-of-racial-inequities-in-preterm-birth/2024-01-24T15:49:51-05:00https://cvvr.hms.harvard.edu/publication/capsid-host-interactions-for-hiv-1-ingress/2024-01-24T15:55:59-05:00https://cvvr.hms.harvard.edu/publication/the-drug-induced-interface-that-drives-hiv-1-integrase-hypermultimerization-and-loss-of-function/2024-01-24T15:58:06-05:00https://cvvr.hms.harvard.edu/publication/the-capsid-lattice-engages-a-bipartite-nup153-motif-to-mediate-nuclear-entry-of-hiv-1-cores/2024-01-24T16:00:59-05:00https://cvvr.hms.harvard.edu/publication/modeling-hiv-1-nuclear-entry-with-nucleoporin-gated-dna-origami-channels/2024-01-24T16:03:12-05:00https://cvvr.hms.harvard.edu/publication/pathways-and-intersections-multifaceted-approaches-to-engage-individuals-from-underrepresented-and-marginalized-communities-in-hiv-research-and-career-development/2024-01-24T16:05:52-05:00https://cvvr.hms.harvard.edu/publication/viral-and-host-mediators-of-non-suppressible-hiv-1-viremia/2024-01-24T16:14:31-05:00https://cvvr.hms.harvard.edu/publication/defining-genetic-diversity-of-rhesus-macaque-fc%ce%b3-receptors-with-long-read-rna-sequencing/2024-02-26T17:55:51-05:00https://cvvr.hms.harvard.edu/publication/a-spatial-cell-atlas-of-neuroblastoma-reveals-developmental-epigenetic-and-spatial-axis-of-tumor-heterogeneity/2024-02-26T18:03:54-05:00https://cvvr.hms.harvard.edu/publication/sars-cov-2-viral-clearance-and-evolution-varies-by-type-and-severity-of-immunodeficiency/2024-02-26T18:09:40-05:00https://cvvr.hms.harvard.edu/publication/waning-immunity-and-igg4-responses-following-bivalent-mrna-boosting/2024-02-27T11:20:32-05:00https://cvvr.hms.harvard.edu/publication/early-initiation-of-antiretroviral-therapy-is-protective-against-seizures-in-children-with-hiv-in-zambia-a-prospective-case-control-study/2024-05-06T09:40:04-04:00https://cvvr.hms.harvard.edu/publication/a-vrc13-like-bnab-response-is-associated-with-complex-escape-pathways-in-hiv-1-envelope/2024-05-06T10:03:11-04:00https://cvvr.hms.harvard.edu/publication/induction-of-durable-remission-by-dual-immunotherapy-in-shiv-infected-art-suppressed-macaques/2024-05-06T10:08:01-04:00https://cvvr.hms.harvard.edu/publication/zeolitic-imidazolate-frameworks-activate-endosomal-toll-like-receptors-and-potentiate-immunogenicity-of-sars-cov-2-spike-protein-trimer/2024-05-06T14:02:39-04:00https://cvvr.hms.harvard.edu/publication/neutralization-of-sars-cov-2-omicron-subvariant-ba-2-87-1/2024-05-06T14:17:07-04:00https://cvvr.hms.harvard.edu/publication/a-microneedle-vaccine-printer-for-thermostable-covid-19-mrna-vaccines-2/2024-05-06T14:22:01-04:00https://cvvr.hms.harvard.edu/publication/a-vrc13-like-bnab-response-is-associated-with-complex-escape-pathways-in-hiv-1-envelope-2/2024-05-06T14:45:18-04:00https://cvvr.hms.harvard.edu/publication/isolation-of-a-recombinant-simian-adenovirus-encoding-the-human-adenovirus-g52-hexon-suggests-a-simian-origin-for-human-adenovirus-g52/2024-05-06T14:48:03-04:00https://cvvr.hms.harvard.edu/publication/covid-19-vaccines-immune-correlates-and-clinical-outcomes/2024-05-06T14:50:19-04:00https://cvvr.hms.harvard.edu/publication/comparison-of-the-immunogenicity-and-protective-efficacy-of-acam2000-mva-and-vectored-subunit-vaccines-for-mpox-in-rhesus-macaques/2024-05-08T09:13:55-04:00https://cvvr.hms.harvard.edu/publication/modeling-resistance-to-the-broadly-neutralizing-antibody-pgt121-in-people-living-with-hiv-1/2024-05-08T08:27:34-04:00https://cvvr.hms.harvard.edu/publication/silencing-of-aryl-hydrocarbon-receptor-repressor-restrains-th17-cell-immunity-in-autoimmune-hepatitis/2024-05-08T08:32:24-04:00https://cvvr.hms.harvard.edu/publication/panini-combined-protein-and-nucleic-acid-imaging-in-tissues/2024-05-08T08:35:32-04:00https://cvvr.hms.harvard.edu/publication/long-term-outcomes-after-new-onset-seizure-in-children-living-with-hiv-a-cohort-study/2024-05-08T08:41:16-04:00https://cvvr.hms.harvard.edu/publication/neutralization-of-sars-cov-2-omicron-subvariant-ba-2-87-1-2/2024-05-08T09:13:02-04:00https://cvvr.hms.harvard.edu/publication/high-frequency-of-prior-severe-acute-respiratory-syndrome-coronavirus-2-infection-by-sensitive-nucleocapsid-assays/2024-05-08T09:47:09-04:00https://cvvr.hms.harvard.edu/publication/b-cell-somatic-hypermutation-following-covid-19-vaccination-with-ad26-cov2-s/2024-05-08T09:57:36-04:00https://cvvr.hms.harvard.edu/publication/chapter-nine-a-hitchhikers-guide-to-high-dimensional-tissue-imaging-with-multiplexed-ion-beam-imaging/2024-05-08T10:19:07-04:00https://cvvr.hms.harvard.edu/publication/intersectional-climate-justice-health-equity-and-hiv/2024-05-08T10:23:49-04:00https://cvvr.hms.harvard.edu/publication/safety-and-immunogenicity-of-a-polyvalent-dna-protein-hiv-vaccine-with-matched-env-immunogens-delivered-as-a-prime-boost-regimen-or-coadministered-in-hiv-uninfected-adults-in-the-usa/2024-05-08T10:25:02-04:00https://cvvr.hms.harvard.edu/publication/the-potential-of-broadly-neutralizing-antibodies-for-hiv-prevention/2024-05-21T16:17:15-04:00https://cvvr.hms.harvard.edu/publication/natural-killer-like-b-cells-are-a-distinct-but-infrequent-innate-immune-cell-subset-modulated-by-siv-infection-of-rhesus-macaques/2024-05-21T16:30:56-04:00https://cvvr.hms.harvard.edu/publication/the-climate-change-burden-on-immune-health-are-persons-living-with-hiv-more-at-risk/2024-05-21T16:33:43-04:00https://cvvr.hms.harvard.edu/publication/vaccine-induction-of-heterologous-hiv-1-neutralizing-antibody-b-cell-lineages-in-humans/2024-05-21T16:38:17-04:00https://cvvr.hms.harvard.edu/publication/the-potential-of-broadly-neutralizing-antibodies-for-hiv-prevention-2/2024-08-15T13:33:28-04:00https://cvvr.hms.harvard.edu/publication/natural-killer-like-b-cells-are-a-distinct-but-infrequent-innate-immune-cell-subset-modulated-by-siv-infection-of-rhesus-macaques-2/2024-08-15T13:36:27-04:00https://cvvr.hms.harvard.edu/publication/the-climate-change-burden-on-immune-health-are-persons-living-with-hiv-more-at-risk-2/2024-08-15T13:47:57-04:00https://cvvr.hms.harvard.edu/publication/vaccine-induction-of-heterologous-hiv-1-neutralizing-antibody-b-cell-lineages-in-humans-2/2024-08-15T13:50:00-04:00https://cvvr.hms.harvard.edu/publication/sars-cov-2-viral-load-in-the-nasopharynx-at-time-of-first-infection-among-unvaccinated-individuals-a-secondary-cross-protocol-analysis-of-4-randomized-trials/2024-09-18T12:02:26-04:00https://cvvr.hms.harvard.edu/publication/human-cd4-binding-site-antibody-elicited-by-polyvalent-dna-prime-protein-boost-vaccine-neutralizes-cross-clade-tier-2-hiv-strains/2024-09-18T12:24:27-04:00https://cvvr.hms.harvard.edu/publication/impact-of-ls-mutation-on-pharmacokinetics-of-preventive-hiv-broadly-neutralizing-monoclonal-antibodies-a-cross-protocol-analysis-of-16-clinical-trials-in-people-without-hiv/2024-09-18T12:28:16-04:00https://cvvr.hms.harvard.edu/publication/knockdowns-of-cd3zeta-chain-in-primary-nk-cells-illustrate-modulation-of-antibody-dependent-cellular-cytotoxicity-against-human-immunodeficiency-virus-1/2024-09-18T12:34:41-04:00https://cvvr.hms.harvard.edu/publication/hiv-1-intasomes-assembled-with-excess-integrase-c-terminal-domain-protein-facilitate-structural-studies-by-cryo-em-and-reveal-the-role-of-the-integrase-c-terminal-tail-in-hiv-1-integration/2024-09-18T12:36:25-04:00https://cvvr.hms.harvard.edu/publication/mosaic-hiv-1-vaccine-regimen-in-southern-african-women-imbokodo-hvtn-705-hpx2008-a-randomised-double-blind-placebo-controlled-phase-2b-trial/2024-09-18T15:43:49-04:00https://cvvr.hms.harvard.edu/publication/prediction-of-differential-gag-versus-env-responses-to-a-mosaic-hiv-1-vaccine-regimen-by-hla-class-i-alleles/2024-09-18T12:41:26-04:00https://cvvr.hms.harvard.edu/publication/fc%ce%b1ri-cd89-is-upregulated-on-subsets-of-mucosal-and-circulating-nk-cells-and-regulates-iga-class-specific-signaling-and-functions/2024-09-18T12:46:07-04:00https://cvvr.hms.harvard.edu/publication/nk-cells-modulate-in-vivo-control-of-sars-cov-2-replication-and-suppression-of-lung-damage/2024-09-18T12:49:34-04:00https://cvvr.hms.harvard.edu/publication/prediction-of-differential-gag-versus-env-responses-to-a-mosaic-hiv-1-vaccine-regimen-by-hla-class-i-alleles-2/2024-09-18T12:51:58-04:00https://cvvr.hms.harvard.edu/publication/nk-cells-modulate-in-vivo-control-of-sars-cov-2-replication-and-suppression-of-lung-damage-2/2024-09-18T13:01:08-04:00https://cvvr.hms.harvard.edu/publication/ad26-m-env-zikv-vaccine-protects-pregnant-rhesus-macaques-and-fetuses-against-zika-virus-infection/2024-09-18T13:03:14-04:00https://cvvr.hms.harvard.edu/publication/graph-fourier-transform-for-spatial-omics-representation-and-analyses-of-complex-organs/2024-09-18T14:58:54-04:00https://cvvr.hms.harvard.edu/publication/patterns-and-predictors-of-covid-19-vaccination-among-young-adults-at-44-us-sites-secondary-analysis-of-a-randomized-controlled-open-label-trial-march-december-2021/2024-09-18T15:03:48-04:00https://cvvr.hms.harvard.edu/publication/germline-targeting-hiv-vaccination-induces-neutralizing-antibodies-to-the-cd4-binding-site/2024-09-18T15:08:54-04:00https://cvvr.hms.harvard.edu/publication/compartment-specific-antibody-correlates-of-protection-to-sars-cov-2-omicron-in-macaques/2024-09-18T15:14:12-04:00https://cvvr.hms.harvard.edu/publication/immune-correlates-analysis-of-the-imbokodo-hvtn-705-hpx2008-efficacy-trial-of-a-mosaic-hiv-1-vaccine-regimen-evaluated-in-southern-african-people-assigned-female-sex-at-birth-a-two-phase-case-contr/2024-09-18T15:16:42-04:00https://cvvr.hms.harvard.edu/publication/insights-from-an-observational-translational-research-program-during-the-covid-19-pandemic-four-years-of-experience/2024-09-18T15:18:30-04:00https://cvvr.hms.harvard.edu/publication/safety-and-antiviral-effect-of-a-triple-combination-of-hiv-1-broadly-neutralizing-antibodies-a-phase-1-2a-trial/2024-09-18T15:20:57-04:00https://cvvr.hms.harvard.edu/publication/hiv-1-usurps-mixed-charge-domain-dependent-cpsf6-phase-separation-for-higher-order-capsid-binding-nuclear-entry-and-viral-dna-integration/2024-09-18T15:23:21-04:00https://cvvr.hms.harvard.edu/publication/mpox-infection-of-stromal-cells-and-macrophages-of-macaque-with-endometriosis/2025-02-18T15:14:23-05:00https://cvvr.hms.harvard.edu/publication/differentiation-of-prior-sars-cov-2-infection-and-postacute-sequelae-by-standard-clinical-laboratory-measurements-in-the-recover-cohort/2025-02-18T15:24:24-05:00https://cvvr.hms.harvard.edu/publication/hiv-vaccine-development-at-a-crossroads-new-b-and-t-cell-approaches/2025-02-18T15:23:09-05:00https://cvvr.hms.harvard.edu/publication/high-frequency-of-prior-severe-acute-respiratory-syndrome-coronavirus-2-infection-by-sensitive-nucleocapsid-assays-2/2025-02-18T15:26:56-05:00https://cvvr.hms.harvard.edu/publication/mosaic-hiv-1-vaccine-and-shiv-challenge-strain-v2-loop-sequence-identity-and-protection-in-primates/2025-02-18T15:33:19-05:00https://cvvr.hms.harvard.edu/publication/decline-of-mpox-antibody-responses-after-modified-vaccinia-ankara-bavarian-nordic-vaccination/2025-02-19T10:15:28-05:00https://cvvr.hms.harvard.edu/publication/immune-correlates-analysis-of-the-imbokodo-hvtn-705-hpx2008-efficacy-trial-of-a-mosaic-hiv-1-vaccine-regimen-evaluated-in-southern-african-people-assigned-female-sex-at-birth-a-two-phase-case-contr-2/2025-02-18T15:53:40-05:00https://cvvr.hms.harvard.edu/publication/the-climate-change-burden-on-immune-health-are-persons-living-with-hiv-more-at-risk-3/2025-02-18T16:03:12-05:00https://cvvr.hms.harvard.edu/publication/measurement-of-circulating-viral-antigens-post-sars-cov-2-infection-in-a-multicohort-study/2025-02-18T16:06:26-05:00https://cvvr.hms.harvard.edu/publication/mosaic-hiv-1-vaccine-regimen-in-southern-african-women-imbokodo-hvtn-705-hpx2008-a-randomised-double-blind-placebo-controlled-phase-2b-trial-2/2025-02-18T16:12:24-05:00https://cvvr.hms.harvard.edu/publication/sars-cov-2-xbb-1-5-mrna-booster-vaccination-elicits-limited-mucosal-immunity/2025-02-18T16:18:51-05:00https://cvvr.hms.harvard.edu/publication/identification-of-a-novel-neutralization-epitope-in-rhesus-aavs/2025-02-19T09:48:51-05:00https://cvvr.hms.harvard.edu/publication/natural-killer-cell-phenotypes-and-clinical-outcomes-in-pediatric-kidney-transplantation/2025-02-19T09:58:06-05:00https://cvvr.hms.harvard.edu/publication/severe-acute-respiratory-syndrome-coronavirus-2-household-transmission-during-the-omicron-era-in-massachusetts-a-prospective-case-ascertained-study-using-genomic-epidemiology/2025-02-19T10:05:35-05:00https://cvvr.hms.harvard.edu/publication/protective-threshold-of-a-potent-neutralizing-zika-virus-monoclonal-antibody-in-rhesus-macaques/2025-02-19T10:09:06-05:00https://cvvr.hms.harvard.edu/publication/in-utero-human-cytomegalovirus-infection-expands-nk-like-fc%ce%b3riiicd8-t-cells-that-mediate-fc-antibody-functions/2025-02-19T10:12:21-05:00https://cvvr.hms.harvard.edu/publication/knockdowns-of-cd3zeta-chain-in-primary-nk-cells-illustrate-modulation-of-antibody-dependent-cellular-cytotoxicity-against-human-immunodeficiency-virus-1-2/2025-02-19T10:14:45-05:00https://cvvr.hms.harvard.edu/publication/a-self-amplifying-rna-rsv-prefusion-f-vaccine-elicits-potent-immunity-in-pre-exposed-and-naive-non-human-primates/2025-02-19T10:31:01-05:00https://cvvr.hms.harvard.edu/publication/measurement-of-circulating-viral-antigens-post-sars-cov-2-infection-in-a-multicohort-study-2/2025-02-19T10:35:35-05:00https://cvvr.hms.harvard.edu/publication/neonatal-immunity-associated-with-heterologous-hiv-1-neutralizing-antibody-induction-in-shiv-infected-rhesus-macaques/2025-02-19T10:38:19-05:00https://cvvr.hms.harvard.edu/publication/nonhuman-primate-antigenic-cartography-of-sars-cov-2/2025-02-19T10:41:59-05:00https://cvvr.hms.harvard.edu/publication/elephant-in-the-room-natural-killer-cells-dont-forget-hiv-either/2025-09-10T15:15:30-04:00https://cvvr.hms.harvard.edu/publication/safety-tolerability-pharmacokinetics-and-neutralisation-activities-of-the-anti-hiv-1-monoclonal-antibody-pgt121-414-ls-administered-alone-and-in-combination-with-vrc07-523ls-in-adults-without-hiv-i/2025-02-19T10:53:01-05:00https://cvvr.hms.harvard.edu/publication/sex-differences-in-long-covid/2025-02-19T10:56:36-05:00https://cvvr.hms.harvard.edu/publication/a-multi-omics-spatial-framework-for-host-microbiome-dissection-within-the-intestinal-tissue-microenvironment/2025-02-19T11:00:48-05:00https://cvvr.hms.harvard.edu/publication/increased-chemokine-production-is-a-hallmark-of-rhesus-macaque-natural-killer-cells-mediating-robust-anti-hiv-envelope-specific-antibody-dependent-cell-mediated-cytotoxicity/2025-02-19T11:05:37-05:00https://cvvr.hms.harvard.edu/publication/protocol-for-identification-and-computational-analysis-of-human-natural-killer-cells-using-flow-cytometry-and-r-star-protoc/2025-05-22T14:06:47-04:00https://cvvr.hms.harvard.edu/publication/physiological-and-pathological-influences/2025-05-22T14:08:01-04:00https://cvvr.hms.harvard.edu/publication/natural-killer-cells-regulate-acute-siv-replication-dissemination-and-inflammation-but-do-not-impact-independent-transmission-events/2025-05-22T14:12:36-04:00https://cvvr.hms.harvard.edu/publication/a-genetically-engineered-stem-cell-derived-cellular-vaccine-2/2025-05-22T14:13:38-04:00https://cvvr.hms.harvard.edu/publication/altered-innate-immunity-and-damaged-epithelial-integrity-in-vaginal-microbial-dysbiosis/2025-05-22T14:14:40-04:00https://cvvr.hms.harvard.edu/publication/mucosal-homing-natural-killer-cells-are-associated-with-aging-in-persons-living-with-hiv/2025-05-22T14:17:17-04:00https://cvvr.hms.harvard.edu/publication/the-functional-diversity-of-tissue-resident-natural-killer-cells-against-infection/2025-05-22T14:18:52-04:00https://cvvr.hms.harvard.edu/publication/learning-to-be-elite-lessons-from-hiv-1-controllers-and-animal-models-on-trained-innate-immunity-and-virus-suppression/2025-05-22T14:23:41-04:00https://cvvr.hms.harvard.edu/publication/adaptive-mhc-e-restricted-tissue-resident-nk-cells-are-associated-with-persistent-low-antigen-load-in-alveolar-macrophages-after-sars-cov-2-infection/2025-05-22T14:30:23-04:00https://cvvr.hms.harvard.edu/publication/increased-il-6-expression-precedes-reliable-viral-detection-in-the-rhesus-macaque-brain-during-acute-siv-infection/2025-05-22T14:31:51-04:00https://cvvr.hms.harvard.edu/publication/probiotic-supplementation-reduces-inflammatory-profiles-but-does-not-prevent-oral-immune-perturbations-during-siv-infection-2/2025-05-22T14:32:57-04:00https://cvvr.hms.harvard.edu/publication/hiv-on-the-brain-is-neurosignalling-damage-irreversible-even-on-antiretroviral-therapy/2025-05-22T14:33:49-04:00https://cvvr.hms.harvard.edu/publication/systemic-and-mucosal-mobilization-of-granulocyte-subsets-during-lentiviral-infection/2025-05-22T14:41:54-04:00https://cvvr.hms.harvard.edu/publication/triggered-could-refocused-cell-signaling-be-key-to-natural-killer-cell-based-hiv-immunotherapeutics-2/2025-05-22T14:43:04-04:00https://cvvr.hms.harvard.edu/publication/skipped-over-tuning-natural-killer-cells-toward-hiv-through-alternative-splicing-2/2025-05-22T14:44:13-04:00https://cvvr.hms.harvard.edu/publication/characterization-of-rhesus-macaque-liver-resident-cd49a-nk-cells-during-retrovirus-infections-2/2025-05-22T14:45:43-04:00https://cvvr.hms.harvard.edu/publication/friends-or-foes-the-knowns-and-unknowns-of-natural-killer-cell-biology-in-covid-19-and-other-coronaviruses-in-july-2020-2/2025-05-22T14:47:52-04:00https://cvvr.hms.harvard.edu/publication/single-shot-ad26-vaccine-protects-against-sars-cov-2-in-rhesus-macaques-2/2025-05-22T14:48:59-04:00https://cvvr.hms.harvard.edu/publication/nonhuman-primate-antigenic-cartography-of-sars-cov-2-2/2025-12-15T11:04:57-05:00https://cvvr.hms.harvard.edu/publication/increased-chemokine-production-is-a-hallmark-of-rhesus-macaque-natural-killer-cells-mediating-robust-anti-hiv-envelope-specific-antibody-dependent-cell-mediated-cytotoxicity-2/2025-12-15T10:15:07-05:00https://cvvr.hms.harvard.edu/publication/points-to-consider-from-the-estp-pathology-2-0-working-group-overview-on-spatial-omics-technologies-supporting-drug-discovery-and-development/2025-12-15T11:05:23-05:00https://cvvr.hms.harvard.edu/publication/the-nuclear-localization-signal-of-cpsf6-governs-post-nuclear-import-steps-of-hiv-1-infection/2025-12-15T11:00:33-05:00https://cvvr.hms.harvard.edu/publication/pharmacokinetic-interaction-assessment-of-an-hiv-broadly-neutralizing-monoclonal-antibody-vrc07-523ls-a-cross-protocol-analysis-of-three-phase-1-trials-in-people-without-hiv/2025-12-15T11:07:14-05:00https://cvvr.hms.harvard.edu/publication/spatiotemporal-binding-of-cyclophilin-a-and-cpsf6-to-capsid-regulates-hiv-1-nuclear-entry-and-integration/2025-12-15T11:16:10-05:00https://cvvr.hms.harvard.edu/publication/on-patient-medical-record-and-mrna-therapeutics-using-intradermal-microneedles/2025-12-15T11:20:40-05:00https://cvvr.hms.harvard.edu/publication/the-primary-mechanism-for-highly-potent-inhibition-of-hiv-1-maturation-by-lenacapavir/2025-12-15T13:43:14-05:00https://cvvr.hms.harvard.edu/publication/longitudinal-analysis-of-rhesus-macaque-metabolome-during-acute-siv-infection-reveals-disruption-in-broad-metabolite-classes/2025-12-15T14:50:33-05:00https://cvvr.hms.harvard.edu/publication/computationally-selected-multivalent-hiv-1-subtype-c-vaccine-protects-against-heterologous-shiv-challenge/2025-12-16T09:52:26-05:00https://cvvr.hms.harvard.edu/publication/fanzors-a-family-of-eukaryotic-rna-guided-dna-endonucleases/2025-12-16T09:59:15-05:00https://cvvr.hms.harvard.edu/publication/structural-and-mechanistic-bases-for-resistance-of-the-m66i-capsid-variant-to-lenacapavir/2025-12-16T10:47:17-05:00https://cvvr.hms.harvard.edu/publication/a-broad-antibody-with-enhanced-hiv-1-neutralization-via-bispecific-antibody-mediated-prepositioning/2025-12-16T11:01:12-05:00https://cvvr.hms.harvard.edu/publication/cpsf6-promotes-hiv-1-preintegration-complex-function/2025-12-16T12:28:17-05:00https://cvvr.hms.harvard.edu/publication/early-spatiotemporal-evolution-of-the-immune-response-elicited-by-adenovirus-serotype-26-vector-vaccination-in-mice/2025-12-16T14:57:24-05:00https://cvvr.hms.harvard.edu/publication/enhanced-interpretation-of-immune-cell-phenotype-and-function-through-a-rhesus-macaque-single-cell-atlas/2025-12-16T16:07:05-05:00https://cvvr.hms.harvard.edu/publication/mapping-essential-somatic-hypermutations-in-a-cd4-binding-site-bnab-informs-hiv-1-vaccine-design/2025-12-16T16:21:16-05:00https://cvvr.hms.harvard.edu/publication/a-comprehensive-engineering-strategy-improves-potency-and-manufacturability-of-a-near-pan-neutralizing-antibody-against-hiv/2025-12-16T16:31:36-05:00https://cvvr.hms.harvard.edu/publication/specific-interactions-between-hiv-1-env-cytoplasmic-tail-and-gag-matrix-domain-probed-by-nmr/2025-12-16T16:39:18-05:00https://cvvr.hms.harvard.edu/publication/next-generation-coronavirus-disease-2019-vaccines-clinical-data-and-future-directions/2025-12-16T16:41:45-05:00https://cvvr.hms.harvard.edu/publication/evaluating-the-test-negative-design-for-covid-19-vaccine-effectiveness-using-randomized-trial-data/2025-12-17T12:23:09-05:00https://cvvr.hms.harvard.edu/publication/safety-pharmacokinetics-and-neutralisation-activity-of-pgdm1400ls-a-v2-specific-hiv-1-broadly-neutralising-antibody-infused-intravenously-or-subcutaneously-in-people-without-hiv-1-in-the-usa-hvtn/2025-12-16T16:57:50-05:00https://cvvr.hms.harvard.edu/publication/timed-chromatin-invasion-during-mitosis-governs-prototype-foamy-virus-integration-site-selection-and-infectivity/2025-12-17T13:20:39-05:00https://cvvr.hms.harvard.edu/publication/siv-proviruses-seeded-later-in-infection-are-harbored-in-short-lived-cd4-t-cells/2025-12-17T14:07:53-05:00https://cvvr.hms.harvard.edu/publication/celllens-enables-cross-domain-information-fusion-for-enhanced-cell-population-delineation-in-single-cell-spatial-omics-data/2025-12-17T14:31:36-05:00https://cvvr.hms.harvard.edu/publication/nonstabilized-sars-cov-2-spike-mrna-vaccination-induces-broadly-neutralizing-antibodies-in-nonhuman-primates/2025-12-17T14:34:55-05:00https://cvvr.hms.harvard.edu/publication/computationally-designed-proteins-mimic-antibody-immune-evasion-in-viral-evolution/2025-12-17T14:37:55-05:00https://cvvr.hms.harvard.edu/publication/the-tumor-microenvironments-role-in-the-response-to-immune-checkpoint-blockade/2025-12-17T14:43:36-05:00https://cvvr.hms.harvard.edu/publication/functional-reprogramming-of-peripheral-eosinophils-in-lentivirus-infected-rhesus-macaques/2025-12-17T14:45:41-05:00https://cvvr.hms.harvard.edu/publication/mucosal-boosting-increases-protective-efficacy-of-an-influenza-vaccine-in-mice/2025-12-17T14:52:33-05:00https://cvvr.hms.harvard.edu/publication/risk-of-severe-outcomes-from-covid-19-in-comorbid-populations-in-the-omicron-era-a-systematic-review-and-meta-analysis/2025-12-17T14:54:57-05:00https://cvvr.hms.harvard.edu/publication/transient-glycan-shield-reduction-induces-cd4-binding-site-broadly-neutralizing-antibodies-in-shiv-infected-macaques/2025-12-17T14:57:39-05:00https://cvvr.hms.harvard.edu/publication/precise-kilobase-scale-genomic-insertions-in-mammalian-cells-using-paste/2025-12-17T15:16:09-05:00https://cvvr.hms.harvard.edu/publication/reprogramming-site-specific-retrotransposon-activity-to-new-dna-sites/2025-12-17T15:17:48-05:00https://cvvr.hms.harvard.edu/publication/antisense-to-human-cd39-dysregulates-immune-metabolism-in-inflammatory-bowel-disease/2025-12-17T15:22:48-05:00https://cvvr.hms.harvard.edu/publication/hiv-1-nuclear-import-is-selective-and-depends-on-both-capsid-elasticity-and-nuclear-pore-adaptability/2025-12-17T15:26:31-05:00https://cvvr.hms.harvard.edu/publication/fixed-dosing-versus-weight-based-dosing-of-hiv-1-prophylactic-monoclonal-antibodies-in-adults-a-post-hoc-cross-protocol-pharmacokinetics-modelling-study-2/2025-12-17T15:28:54-05:00https://cvvr.hms.harvard.edu/publication/adenovirus-and-mrna-vaccines-as-well-as-mucosal-boosting-improve-protective-efficacy-against-influenza-virus-challenge-in-macaques/2025-12-17T15:30:55-05:00https://cvvr.hms.harvard.edu/publication/interferon-responsive-hevs-drive-tumor-tertiary-lymphoid-structure-formation-and-predict-immunotherapy-response-in-nasopharyngeal-carcinoma-2/2025-12-17T15:46:03-05:00https://cvvr.hms.harvard.edu/publication/high-frequency-of-chronic-urticaria-following-an-investigational-hiv-1-bg505-md39-3-trimer-mrna-vaccine-in-a-phase-1-randomized-open-label-clinical-trial-hvtn-302/2025-12-18T10:22:49-05:00https://cvvr.hms.harvard.edu/publication/vaccination-with-mrna-encoded-membrane-anchored-hiv-envelope-trimers-elicited-tier-2-neutralizing-antibodies-in-a-phase-1-clinical-trial/2025-12-18T10:25:13-05:00https://cvvr.hms.harvard.edu/publication/retrointegration2023-papers-from-the-7th-international-conference-on-retroviral-integration/2025-12-18T10:32:59-05:00https://cvvr.hms.harvard.edu/publication/association-of-glucagon-like-peptide-1-receptor-agonists-with-cancer-risk-in-older-adults-with-type-2-diabetes/2025-12-18T10:38:40-05:00https://cvvr.hms.harvard.edu/publication/structural-and-genetic-basis-of-hiv-1-envelope-v2-apex-recognition-by-rhesus-broadly-neutralizing-antibodies/2026-02-02T09:43:14-05:00https://cvvr.hms.harvard.edu/publication/a-novel-approach-for-preventing-respiratory-virus-infections/2026-02-02T10:28:18-05:00https://cvvr.hms.harvard.edu/publication/epstein-barr-virus-exploits-desmocollin-2-as-the-principal-epithelial-cell-entry-receptor/2026-02-02T10:58:15-05:00https://cvvr.hms.harvard.edu/publication/myeloid-cell-recruitment-and-activation-through-systemic-and-mucosae-directed-cytokine-therapy/2026-02-02T11:04:54-05:00https://cvvr.hms.harvard.edu/publication/immunogenicity-of-jn-1-and-kp-2-covid-19-mrna-vaccines-against-emerging-sars-cov-2-variants/2026-02-02T11:10:05-05:00https://cvvr.hms.harvard.edu/publication/mining-the-cd4-antigen-repertoire-for-next-generation-tuberculosis-vaccines/2026-02-02T11:13:12-05:00https://cvvr.hms.harvard.edu/publication/hydrogel-formulations-for-sustained-release-of-broadly-neutralizing-antibodies/2026-02-02T11:15:32-05:00https://cvvr.hms.harvard.edu/publication/stabilizers-silencers-and-disease-stage-lessons-from-recent-trials-of-attr-cardiac-amyloidosis/2026-02-02T11:22:25-05:00https://cvvr.hms.harvard.edu/publication/building-a-better-natural-killer-nk-cell-fc-receptor-engineering-strategies-for-nk-cell-therapeutics/2026-02-02T11:41:22-05:00https://cvvr.hms.harvard.edu/publication/reflections-on-advances-in-cancer-research-in-2025/2026-02-02T11:27:02-05:00https://cvvr.hms.harvard.edu/publication/long-covid-involves-activation-of-proinflammatory-and-immune-exhaustion-pathways/2026-02-02T11:38:26-05:00https://cvvr.hms.harvard.edu/publication/minor-shiv-variants-abrogate-protective-efficacy-of-broadly-neutralizing-antibodies-in-rhesus-macaques/2026-02-02T11:36:55-05:00https://cvvr.hms.harvard.edu/publication/application-of-a-novel-branched-dna-assay-to-quantify-killer-immunoglobulin-like-receptor-kir-mrna-expression-identifies-tissue-compartmentalization-in-naive-and-siv-infected-rhesus-macaques/2026-02-02T11:46:01-05:00https://cvvr.hms.harvard.edu/publication/elevated-peripheral-and-nervous-system-inflammation-is-associated-with-decreased-short-chain-fatty-acid-levels-in-zika-virus-infected-macaques/2026-02-02T11:58:57-05:00https://cvvr.hms.harvard.edu/publication/immunopathogenesis-of-lethal-h5n1-avian-influenza-virus-clade-2-3-4-4b-infection-in-macaques/2026-02-02T12:04:59-05:00https://cvvr.hms.harvard.edu/publication/corrigendum-to-immune-correlates-analysis-of-the-imbokodo-hvtn-705-hpx2008-efficacy-trial-of-a-mosaic-hiv-1-vaccine-regimen-evaluated-in-southern-african-people-assigned-female-sex-at-birth/2026-02-02T12:07:49-05:00https://cvvr.hms.harvard.edu/publication/anti-il-15-treatment-reduces-acute-lentivirus-inflammation-and-signaling-in-the-brain/2026-02-02T12:12:36-05:00https://cvvr.hms.harvard.edu/publication/development-and-validation-of-hiv-smrtcap-for-the-characterization-of-hiv-1-reservoirs-across-tissues-and-subtypes/2026-02-02T14:57:03-05:00https://cvvr.hms.harvard.edu/publication/associations-between-the-microbiome-and-immune-responses-to-an-adenovirus-based-hiv-1-candidate-vaccine-are-distinct-between-african-and-us-cohorts/2026-02-03T12:31:06-05:00